adenosine has been researched along with Auricular Fibrillation in 230 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (0.87) | 18.7374 |
| 1990's | 31 (13.48) | 18.2507 |
| 2000's | 50 (21.74) | 29.6817 |
| 2010's | 118 (51.30) | 24.3611 |
| 2020's | 29 (12.61) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, H; Kataoka, M; Kohno, R; Miyamoto, T; Oginosawa, Y; Ohe, H; Tsukahara, K; Yagyu, K; Yamagishi, Y | 1 |
| Aldhoon, B; Kautzner, J; Konečný, P; Osmančík, P; Peichl, P; Wichterle, D | 1 |
| Janga, C; Killu, AM; Madhavan, M; Siontis, KC | 1 |
| Betts, TR; Briosa E Gala, A; Kuklik, P; Leo, M; Mahmoudi, M; Paisey, J; Pope, MTB | 1 |
| Aydin, A; Burns, K; Cicero, MX; Cone, DC; Couturier, K; Joseph, D; Nelson, AR; Rollins, M; Shapiro, M | 1 |
| Ang, R; Butcher, C; Chow, A; Creta, A; Dhinoja, M; Earley, MJ; Finlay, MC; Honarbakhsh, S; Hunter, RJ; Kanthasamy, V; Lambiase, PD; Lim, W; Martin, CA; Providencia, R; Schilling, RJ; Sohaib, A; Sporton, S; Srinivasan, NT; Waddingham, PH | 1 |
| Himi, T; Ishimura, M; Kobayashi, Y; Yamamoto, M | 1 |
| Berdaoui, B; Castro Rodriguez, J; Morissens, M; Pintea Bentea, G; Samyn, S; Van de Borne, P | 1 |
| Goto, H; Hasegawa, S; Ishiguro, N; Kametani, R; Kato, K; Kikuchi, S; Shibata, N; Tanaka, A; Tominaga, S; Uehara, Y | 1 |
| Bentzen, BH; Ciruela, F; Ginel, A; Godoy-Marín, H; Hove-Madsen, L; Jiménez-Sábado, V; Santos, JLD; Tarifa, C | 1 |
| Guan, W; Guo, J; Li, X; Liu, J; Niu, G; Xia, Y; Yao, Y | 1 |
| Cheung, CC; Chieng, D; Dewland, TA; Dillon, W; Gerstenfeld, EP; Hsia, HH; Kistler, PM; Lee, AC; Lee, BK; Lee, RJ; Marcus, GM; Moss, JD; Tseng, ZH; Vedantham, V; Vittinghoff, E; Voskoboinik, A; Yogi, S | 1 |
| Arenella, M; Cioffi, S; Cosimi, R; De Nigris, A; De Simone, C; Di Nardo, G; Giannattasio, A; Lauretta, D; Marco, GMD; Martemucci, L; Marzuillo, P; Mormile, A; Pepe, A; Perrotta, S; Salomone, G; Tipo, V; Vastarella, R | 1 |
| Rekik, S | 1 |
| Arya, A; Bollmann, A; Hindricks, G; Jahnke, C; Kircher, S; Lindemann, F; Oebel, S; Paetsch, I; Sommer, P; Stegmann, C | 1 |
| Coromilas, J; Kassotis, J; Kostis, WJ; Maglione, T; Pagan, E; Saluja, D | 1 |
| Andrade, JG; Badra-Verdu, M; Champagne, J; Deyell, MW; Dubuc, M; Jolly, U; Khairy, P; Leong-Sit, P; Macle, L; Nattel, S; Sapp, J; Verma, A | 1 |
| Fredersdorf, S; Hauck, C; Jungbauer, C; Maier, L; Poschenrieder, F; Seegers, J; Üçer, E | 1 |
| Fredersdorf, S; Hauck, C; Jungbauer, C; Kaufmann, M; Maier, L; Poschenrieder, F; Ücer, E | 1 |
| Cernicek, V; Fedorco, M; Hutyra, M; Klementova, O; Moravec, O; Precek, J; Skala, T; Skalova, J; Taborsky, M; Tudos, Z; Zapletalova, J | 1 |
| Arbelo, E; Blomström-Lundqvist, C; Brugada, J; Crijns, HJGM; Da Costa, A; Dagres, N; Delhaas, T; Laroche, C; Pison, L; Pytkowski, M; Sharikov, N; Tavazzi, L; van Rosmalen, F | 1 |
| Bruner, D; Bruner, H; Clark, DD; Jones, M; McGuire, M | 1 |
| Cismaru, A; Cismaru, G; Gusetu, G; Istratoaie, S; Pop, D; Puiu, M; Rosu, R; Zdrenghea, D | 1 |
| Abe, H; Kohno, R; Miyamoto, T; Oginosawa, Y; Ohe, H; Otsuji, Y; Tsukahara, K; Yamagishi, Y | 1 |
| Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
| Ajioka, M; Asano, H; Hiramatsu, S; Hosono, H; Kanbara, T; Kondo, S; Kurokawa, H; Matsumoto, H; Miyamoto, S; Nakashima, Y; Osanai, H; Sakamoto, Y; Tagahara, K; Tokuda, K; Uno, H | 1 |
| Afzal, MR; Artiga, EJ; Dastagir, N; Fedorov, VV; Hansen, BJ; Helfrich, KM; Houmsse, MM; Hummel, JD; Iancau, A; Janssen, PML; Kahaly, O; Kalyanasundaram, A; Li, N; Mohler, PJ; Mokadam, NA; Salgia, N; Sharma, R; Simonetti, OP; Subr, M; Whitson, BA; Zakharkin, SO; Zhao, J; Zolotarev, AM | 1 |
| Auricchio, A; Brugada, P; Caputo, ML; Chierchia, GB; Conte, G; De Asmundis, C; Demarchi, A; Gharaviri, A; Klersy, C; Moccetti, T; Neumann, L; Özkartal, T; Pezzuto, S; Regoli, F; Salghetti, F; Schotten, U | 1 |
| Abbass, H; Ahluwalia, N; Chow, A; Creta, A; Dhillon, GS; Earley, MJ; Graham, A; Honarbakhsh, S; Hunter, RJ; Lambiase, PD; Schilling, RJ | 1 |
| Ciruela, F; Colino-Lage, H; Duroux, R; Godoy-Marín, H; Hove-Madsen, L; Jacobson, KA; Jiménez-Sábado, V; Montiel, J; Soler, C | 1 |
| Chen, YH; Hou, JW; Li, YG; Lin, H; Xie, CL | 1 |
| Pascale, P; Pruvot, E; Roten, L | 1 |
| Kistler, PM; Prabhu, S | 1 |
| Pelleg, A | 1 |
| Battaglia, A; Bianchi, F; Biondi-Zoccai, G; Blandino, A; Conte, MR; Gaita, F; Grossi, S; Rametta, F | 1 |
| Cha, MJ; Choi, EK; Oh, S | 1 |
| Kanagaratnam, A; Kumar, N; Phan, K; Phan, S; Wang, N | 1 |
| Bhatt, DL; Cannon, CP; Ellis, SG; Gropper, S; Harper, R; Hohnloser, SH; Januzzi, JL; Kimura, T; Kleine, E; Lip, GYH; Maeng, M; Manassie, J; Merkely, B; Nordaby, M; Oldgren, J; Steg, PG; Ten Berg, JM; Zeymer, U | 1 |
| AlTurki, A; Marshall, HJ; Proietti, R | 1 |
| Fujita, M; Iida, O; Ishihara, T; Kanda, T; Masuda, M; Matsuda, Y; Nanto, K; Ohashi, T; Okamoto, S; Sunaga, A; Tsujimura, T; Uematsu, M | 1 |
| Cummings, J; Farid, T; Khan, AR; Khawaja, O; Luni, FK; Malik, SA; Riaz, H; Singh, H; Taleb, M | 1 |
| Fredersdorf, S; Friemel, S; Janeczko, Y; Jungbauer, CG; Maier, LS; Poschenrieder, F; Seegers, J; Ücer, E | 1 |
| Afzal, MR; Daoud, EG; Houmsse, M; Hummel, JD; Kahaly, O; Weiss, R | 1 |
| Gupta, D; Hall, M; Mahida, S; Maille, B; Modi, S; Snowdon, R; Todd, D; Waktare, J; Wynn, G | 1 |
| Bencsik, G; Makai, A; Pap, R; Riesz, T; Saghy, L; Tutuianu, C | 1 |
| Bottone, S; Boussuges, A; Chefrour, M; Deharo, JC; Deharo, P; Fenouillet, E; Franceschi, F; Gastaldi, M; Gaudry, M; Gueant, JL; Gueant, R; Guieu, R; Guiol, C; Koutbi, L; Mace, P; Maille, B; Marlinge, M; Martinez, E; Michelet, P; Mottola, G; Ruf, J; Vairo, D | 1 |
| Antonicka, A; Hutyra, M; Klementova, O; Moravec, O; Precek, J; Skala, T; Skalova, J; Taborsky, M; Tudos, Z; Zapletalova, J | 1 |
| Noseworthy, PA; Siontis, KC | 1 |
| Heidbuchel, H; Sarkozy, A; Spera, FR | 1 |
| Iesaka, Y; Kusa, S; Miyazaki, S | 1 |
| Kalman, JM; Kistler, PM; Kumar, S; McLellan, AJ; Morton, JB; Smith, C | 1 |
| Sylvén, C; Y-Hassan, S | 1 |
| Stiefelhagen, P | 1 |
| Dobson, GP; Vinten-Johansen, J | 1 |
| Jakobsen, Ø; Steensrud, T | 1 |
| Cheung, JW; Chung, JH; Ip, JE; Lerman, BB; Liu, CF; Markowitz, SM; Thomas, G | 2 |
| Hachiya, H; Hirao, K; Iesaka, Y; Kusa, S; Miyazaki, S; Nakamura, H; Taniguchi, H; Uchiyama, T | 1 |
| Andrade, JG; Dubuc, M; Dyrda, K; Guerra, PG; Khairy, P; Macle, L; Mondesert, B; Nattel, S; Rivard, L; Roy, D; Talajic, M; Thibault, B; Vanella, A | 1 |
| Brunelli, M; Frommhold, M; Geller, JC; Große, A; Hanazawa, K; Raffa, S; Roos, M; Sammut, M; Wauters, K | 1 |
| Corino, VD; Holmqvist, F; Mainardi, LT; Platonov, PG | 1 |
| Jaïs, P; Lim, HS | 1 |
| Bai, R; Bailey, S; Beheiry, S; Burkhardt, JD; Di Biase, L; Elayi, CS; Gallinghouse, GJ; Hongo, R; Horton, R; Mohanty, P; Natale, A; Sanchez, J; Santangeli, P | 1 |
| Arentz, T; Jadidi, AS | 1 |
| Kaitani, K; Kobori, A; Kurotobi, T; Nakagawa, Y; Nakazawa, Y; Okajima, K; Yao, T | 1 |
| Knecht, S; Pascale, P; Shah, AJ | 1 |
| Bender, SR; Cheung, JW; Ip, JE; Lerman, BB; Lin, FS; Liu, CF; Markowitz, SM; Siddiqi, FK; Thomas, G | 1 |
| Anter, E; Contreras-Valdes, FM; Josephson, ME; Shvilkin, A; Tschabrunn, CM | 1 |
| Angiolillo, DJ; Capodanno, D | 1 |
| Allgeier, J; Arentz, T; Jadidi, AS; Keyl, C; Lehrmann, H; Neumann, FJ; Park, CI; Schiebeling, J; Schurr, P; Shah, A; Weber, R | 1 |
| Baltogiannis, G; Brugada, P; Catanzariti, D; Chierchia, GB; Ciconte, G; Conte, G; DE Asmundis, C; DI Giovanni, G; Juliá, J; Mugnai, G; Saitoh, Y; Sieira, J; Tondo, C; Wauters, K | 1 |
| Biesiadecki, BJ; Billman, GE; Carnes, CA; Csepe, TA; Fedorenko, O; Fedorov, VV; Glukhov, AV; Györke, S; Hage, LT; Hansen, BJ; Kalyanasundaram, A; Li, N; Lou, Q; Mohler, PJ; Weiss, R | 1 |
| Blaauw, Y; Crijns, H; Kumar, N; Pison, L; Timmermans, C; Vernooy, K | 1 |
| Biviano, AB; Ciaccio, EJ; Garan, H; Jacobson, JT; Whang, W | 1 |
| Haïssaguerre, M; Hocini, M; Jaïs, P; Shah, AJ; Weerasooriya, R | 1 |
| Gundlapalli, S; Idris, S; Shah, DP | 1 |
| Cheung, JW; Ip, JE; Lerman, BB; Liez, J; Liu, CF; Markowitz, SM; Spotnitz, MD; Thomas, G | 1 |
| Callans, D; Chik, W; Liuba, I; Maeda, S; Marchlinski, FE; Santangeli, P; Squara, F; Zado, ES | 1 |
| Bico, B; Braun, OÖ; Chaudhry, U; Gustav Smith, J; Jovinge, S; Koul, S; Scherstén, F; Svensson, PJ; Tydén, P; van der Pals, J; Wagner, H | 1 |
| Chen, L; Fu, C; Lu, W; Ma, G; Wang, Y; Yao, Y; Zuo, P | 1 |
| Corino, VD; Mainardi, LT; Platonov, PG; Sandberg, F; Sörnmo, L | 1 |
| Anvardeen, K; Barbraud, C; De Meester, C; Goesaert, C; le Polain de Waroux, JB; Marchandise, S; Reis, I; Scavee, C; Weerasooriya, R | 1 |
| Cheung, JW; Ip, JE; Lerman, BB; Lin, FS; Liu, CF; Markowitz, SM; Thomas, G | 1 |
| Debl, K; Fredersdorf, S; Jungbauer, CG; Maier, LS; Riegger, G; Seegers, J; Üçer, E | 1 |
| Compier, MG; De Riva, M; Dyrda, K; Schalij, MJ; Trines, SA; Zeppenfeld, K | 1 |
| Crijns, HJ; Dassen, W; Dinh, T; Kumar, N; Maessen, J; Phan, K; Philippens, S; Pison, L; Timmermans, C; Vranken, N | 1 |
| Gao, F; Liu, XL; Shen, H; Wang, ZJ; Yang, SW; Zhou, YJ | 1 |
| Bergmann, L; Dedroogh, M; Gaudin, D; Höfer, C; Rühmkorf, K; Tebbenjohanns, J; von Werder, A | 1 |
| Kumar, N; Lozekoot, P | 1 |
| Akbulak, R; Hoffmann, BA; Kuklik, P; Lüker, J; Moser, J; Schaeffer, B; Schreiber, D; Steven, D; Sultan, A; Willems, S | 1 |
| Andrade, JG; Arentz, T; Deisenhofer, I; Dubuc, M; Guerra, PG; Jaïs, P; Khairy, P; Levesque, S; Macle, L; Nattel, S; Novak, P; Puererfellner, H; Rivard, L; Roy, D; Scavée, C; Talajic, M; Thibault, B; Veenhuyzen, G; Verma, A; Weerasooriya, R; Willems, S | 1 |
| Datino, T | 1 |
| Huynh, K | 1 |
| Bock, K; Himmrich, E; Kämpfner, D; Konrad, T; Mollnau, H; Münzel, T; Ocete, BQ; Potstawa, M; Rostock, T; Sonnenschein, S; Theis, C | 1 |
| Isilak, Z; Temizkan, V; Uz, O | 1 |
| Jared Bunch, T | 1 |
| Al-Assad, W; Ansari, S; Bogun, F; Chugh, A; Crawford, T; Ghanbari, H; Huether, E; Hussain-Amin, A; Jani, R; Jongnarangsin, K; Latchamsetty, R; Morady, F; Oral, H | 1 |
| Belhassen, B; Michowitz, Y | 1 |
| Macle, L; Nattel, S | 1 |
| Clauss, S; Estner, HL; Fichtner, S; Hilberath, JN; Kääb, S; Klocker, E; Olesch, L; Sarai, S; Sattler, S; Siebermair, J; Sinner, MF; Wakili, R | 1 |
| Gerstenfeld, EP; Roberts, JD | 1 |
| Jang, SW; Kim, JH; Kim, JY; Kim, SH; Kim, TS; Kim, YR; Lee, MY; Oh, YS; Rho, TH; Song, IG | 1 |
| Chen, KY; Li, G; Liu, T; Xu, G; Zhang, N; Zhao, J | 1 |
| Hirayama, A; Iso, K; Kogawa, R; Kurokawa, S; Nagashima, K; Nakai, T; Ohkubo, K; Okumura, Y; Sasaki, N; Sonoda, K; Takahashi, K; Watanabe, I | 1 |
| Asirvatham, SJ; Deshmukh, A; Kapa, S; Killu, A; Mulpuru, SK | 1 |
| Biesiadecki, BJ; Csepe, TA; Fedorov, VV; Guha, A; Hansen, BJ; Hummel, JD; Janssen, PM; Kalyanasundaram, A; Kilic, A; Li, N; Mohler, PJ; Sul, LV; Van Wagoner, DR; Weiss, R; Zakharkin, SO; Zhao, J | 1 |
| Chugh, A | 1 |
| Andrade, JG; Arentz, T; Deisenhofer, I; Dubuc, M; Dyrda, K; Guerra, PG; Hoffmann, BA; Khairy, P; Levesque, S; Macle, L; Mondesert, B; Nattel, S; Novak, P; Rivard, L; Rostock, T; Roy, D; Steven, D; Talajic, M; Thibault, B; Verma, A; Weerasooriya, R; Willems, S | 1 |
| Clappers, N; Hassink, RJ; Kassenberg, W; Loh, P; Teunissen, C; van der Heijden, JF | 1 |
| Azzopardi, SM; Kalman, JM; Kistler, PM; Lee, G; Ling, LH; Mackin, V; Mariani, J; McGlade, D; McLellan, AJ; Nalliah, CJ; Pathik, B; Peck, KY; Phan, T; Prabhu, S; Taylor, AJ; Voskoboinik, A; Wong, GR | 1 |
| Adragão, P; Bronis, K; Cavaco, D; Chow, A; Costa, FM; Hunter, RJ; Lambiase, PD; Lowe, M; Papageorgiou, N; Providência, R; Rowland, E; Schilling, RJ; Segal, OR; Srinivasan, N; Tousoulis, D | 1 |
| He, YM | 1 |
| Fedorov, VV; Hansen, BJ; Li, N | 1 |
| Ha, YW; Kim, SH; Oh, YS; Park, JW | 1 |
| Bravo, JC; Fontanals, J; Magaldi, M; Masgoret, P; Montero-Tinnirello, J | 1 |
| Amstalden, H; Beer, JH; Benussi, S; Bonetti, NR; Breitenstein, A; Camici, GG; Falk, V; Glanzmann, M; Holy, EW; Keller, S; Lüscher, TF; Maisano, F; Reiner, MF; Savarese, G; Stämpfli, SF; Steffel, J | 1 |
| Kalman, JM; Kistler, PM; Kumar, S; Ling, LH; McLellan, AJA; Prabhu, S; Smith, C | 1 |
| Kalman, JM; Kistler, PM; Lee, G; McLellan, AJA; Morris, GM; Morton, JB; Nisbet, A; Pathik, B; Prabhu, S; Voskoboinik, A; Walters, TE; Wong, MCG | 1 |
| Crijns, HJ; La Meir, M; Maessen, JG; Pison, L; Vroomen, M | 1 |
| Fleck, E; Gerds-Li, H; Kriatselis, C; Roser, M; Tang, M | 1 |
| Acil, T; Breithardt, G; Hermann, S; Kies, P; Paul, M; Range, FT; Schäfers, KP; Schäfers, MA; Schober, O; Wichter, T | 1 |
| Fan, YQ; Fu, GS; Jiang, CY; Jiang, RH; Liu, Q; Matsuo, S; Zhang, ZW | 1 |
| Hindricks, G; Kottkamp, H | 1 |
| Brunelli, M; Geller, JC; Grosse, A; Raffa, S; Regoli, F | 1 |
| Brugada, P; Capulzini, L; Chierchia, GB; de Asmundis, C; De Ponti, R; Duytschaever, M; Sarkozy, A; Sorgente, A; Yazaki, Y | 1 |
| Avram, MJ; Batjer, HH; Bebawy, JF; Bendok, BR; Gupta, DK; Hemmer, LB; Koht, A; Zeeni, C | 1 |
| Abe, K; Aramaki, Y; Date, T; Hioki, M; Inada, K; Ito, K; Lellouche, N; Matsuo, S; Miyanaga, S; Miyazaki, H; Nakane, T; Narui, R; Shibayama, K; Sugimoto, K; Tanigawa, S; Taniguchi, I; Tokuda, M; Tokutake, K; Yamane, T; Yamashita, S; Yoshida, H; Yoshimura, M | 1 |
| Fox, DJ; Gray, C; Gula, LJ; Klein, GJ; Krahn, AD; Leong-Sit, P; Massel, D; Segal, OR; Skanes, AC; Yee, R | 1 |
| Nair, KK; Namboodiri, N; Thajudeen, A; Tharakan, JM; Valaparambil, AK | 1 |
| Chen, SA; Chen, YC; Chen, YJ; Lin, YK; Tsai, WC | 1 |
| Chartier, D; Comtois, P; Datino, T; Fernandez-Aviles, F; Guerra, PG; Khairy, P; Macle, L; Nattel, S | 1 |
| Lazzara, R | 1 |
| García Urra, F; Luque Lezcano, O; Porres Aracama, JM | 1 |
| Isobe, M; Kobori, A; Kuwahara, T; Miyazaki, S; Sato, A; Takahashi, A; Takahashi, Y; Takei, A | 1 |
| Kowal, RC | 1 |
| Almendral, J; Castellanos, E; Hadid, C; Ortiz, M; Perez-David, E; Robles, P | 1 |
| d'Avila, A; Dukkipati, SR; Eggert, C; Fischer, A; Gomes, JA; Koruth, JS; Miller, MA; Napolitano, C; Reddy, VY; Viles-Gonzalez, J | 1 |
| Nattel, S | 1 |
| Castro-Rodriguez, J; Janssen, C; Knecht, S; Verbeet, T | 1 |
| d'Avila, A; Miller, MA; Viles-Gonzalez, JF | 1 |
| De Potter, TJ; Eisenberger, M; Geelen, P; McCann, C; Peytchev, P | 1 |
| Cheung, JW; Chung, JH; Ip, JE; Lee, JM; Lerman, BB; Lessner, SJ; Liu, CF; Markowitz, SM; Thomas, G | 1 |
| Reed, SD | 1 |
| Aas, KN; Jakobsen, Ø; Næsheim, T; Steensrud, T; Sørlie, D | 1 |
| Collart, F; Deharo, JC; Franceschi, F; Gariboldi, V; Giorgi, R; Gravier, G; Guieu, R; Kerbaul, F; Michelet, P; Nee, L; Resseguier, N | 1 |
| Bayer, JD; Clopton, P; Ho, G; Ho, J; Krummen, DE; Narayan, SM; Smetak, MR; Trayanova, NA | 1 |
| Hachiya, H; Iesaka, Y; Kusa, S; Miyazaki, S; Nakamura, H; Taniguchi, H; Uchiyama, T | 1 |
| Hachiya, H; Hirao, K; Iesaka, Y; Isobe, M; Kobori, A; Komatsu, Y; Kusa, S; Kuwahara, T; Miyazaki, S; Takahashi, A; Taniguchi, H; Uchiyama, T | 1 |
| De Greef, Y; De Keulenaer, G; Duytschaever, M; Schwagten, B; Stockman, D; Tavernier, R | 1 |
| Park, E; Price, A; Vidovich, MI | 1 |
| Hachiya, H; Haïssaguerre, M; Hirao, K; Hocini, M; Iesaka, Y; Isobe, M; Kobori, A; Komatsu, Y; Kusa, S; Miyazaki, S; Nakamura, H; Shah, AJ; Takahashi, A; Taniguchi, H; Uchiyama, T | 1 |
| Chan, KH; Sy, RW | 1 |
| Miller, JM; Williams, ES | 1 |
| García Alberola, A; Gómez Agüera, A; Llamas Lázaro, C; Martínez Sánchez, J; Sánchez Muñoz, JJ; Valdés Chávarri, M | 1 |
| Klemm, H; Meinertz, T; Sturm, N; Ventura, R; Weiss, C; Willems, S | 1 |
| Borchard, R; Brandts, B; Dirkmann, D; Prull, MW; Sievers, B; Trappe, HJ; van Bracht, M; Wickenbrock, I | 1 |
| Cheung, JW; Lerman, BB | 1 |
| Ahmed, H; Chu, N; Gao, Z; Ibrahim, P; Leung, K; Li, Z; Ozeck, M; Palle, VP; Varkhedkar, V; Wu, L; Wu, Y; Zablocki, JA; Zeng, D | 1 |
| Belardinelli, L; Shryock, J; Wu, L; Zablocki, JA | 1 |
| Raviña, P; Raviña, T; Suárez, ML | 1 |
| Aslan, R; Bebooul, Y; Bertolet, B; Kutsal, A; Ocal, A; Tunerir, B; Yavuz, T; Ybribim, E | 1 |
| Callans, DJ; Dixit, S; Gerstenfeld, EP; Marchlinski, FE | 1 |
| Pelosi, F | 1 |
| Arentz, T; Haissaguerre, M; Hocini, M; Jais, P; Kalusche, D; Macle, L; Shah, D | 1 |
| Antz, M; Bänsch, D; Chen, M; Chun, J; Ernst, S; Falk, P; Hachiya, H; Khanedani, A; Kuck, KH; Ouyang, F; Schaumann, A | 1 |
| De Ponti, R; Lanzotti, M; Marazzi, R; Moretti, P; Salerno-Uriarte, JA; Spadacini, G; Tritto, M | 1 |
| Chizzola, G; Copetti, R; Paolo Pillinini, P; Proclemer, A | 1 |
| Abdul-Karim, A; Bhargava, M; Burkhardt, D; Erciyes, D; Khaykin, Y; Marrouche, N; Martin, DO; Natale, A; Rossillo, A; Saliba, W; Schweikert, R; Verma, A; Wazni, OM | 1 |
| Kaltman, JR; Rhodes, LA; Shah, MJ; Tanel, RE; Vetter, VL | 1 |
| Alonso, R; Doblado, M; Isa-Param, R; Macaya, C; Morales, R; Moreno, J; Pérez-Castellano, N; Ruiz, E; Salinas, J; Villacastín, J | 1 |
| Abrams, DJ; Earley, MJ; Schilling, RJ; Sporton, SC | 1 |
| Cummings, M; Movahed, A; Raza, J | 1 |
| Kao, SL; Ooi, S | 1 |
| Almendral, J; Arenal, A; Atienza, F; Berenfeld, O; Jalife, J; Kalifa, J; Moreno, J; Ploutz-Snyder, R; Sánchez, A; Talkachou, A; Torrecilla, EG; Vaidyanathan, R; Villacastín, JP | 1 |
| Haïssaguerre, M; O'Neill, MD; Rostock, T; Sanders, P; Takahashi, Y | 1 |
| Atienza, F; Jalife, J | 1 |
| Chang, SL; Chen, SA; Lin, YJ; Tuan, TC | 1 |
| Banchs, JE; Gonzalez, MD; Naccarelli, GV; Penny-Peterson, E; Samii, S; Wolbrette, DL | 1 |
| Hanon, S; Kanei, Y; Schweitzer, P; Van-Tosh, A | 1 |
| Berenfeld, O | 1 |
| Boyle, NG; Buch, E; Celigoj, A; Cesario, D; De Diego, C; Garfinkel, A; Lellouche, N; Mahajan, A; Shivkumar, K; Siegerman, C; Wiener, I | 1 |
| Lim, PB; O'Neill, MD; Peters, NS; Stuber, T | 1 |
| Murray, S; Thambyrajah, J; Turley, AJ | 1 |
| Carey, PA; Taggar, JS | 1 |
| Greenfield, JC; McHale, PA; Rembert, JC | 1 |
| Jung, W; Lüderitz, B; Manz, M; Pfeiffer, D; Schumacher, B; Tebbenjohanns, J | 1 |
| Farber, P; Furlong, R; Gerhardt, RT; Pittaluga, J; Schrank, K; Willig, R | 1 |
| Botteron, GW; Smith, JM | 2 |
| Belardinelli, L; Buchanan, LV; Gibson, JK; Kabell, G | 1 |
| Crosson, JE; Dunnigan, A; Etheridge, SP; Hesslein, PS; Milstein, S | 1 |
| Cowell, RP; Ilsley, CD; Paul, VE | 1 |
| Camm, J; Connelly, DT; Garratt, CJ; Griffith, MJ; O'Nunain, S; Rowland, E; Ward, DE | 1 |
| Ben-Sorek, ES; Wiesel, J | 1 |
| White, RD | 1 |
| Baga, JJ; Lehmann, MH; Machado, C; Meissner, MD; Silverman, AJ; Steinman, RT | 1 |
| Raev, D | 1 |
| Belardinelli, L; Bertolet, BD; Hill, JA; Kerensky, RA | 1 |
| Bahu, M; Brinkman, K; Daoud, EG; Goyal, R; Knight, BP; Man, KC; Morady, F; Strickberger, SA; Weiss, R | 1 |
| Gibbons, RJ; Hodge, DO; Hopfenspirger, MR; Johnston, DL | 1 |
| Ellenbogen, KA; Gilligan, DM; Natale, A; Shepard, RK; Stambler, BS; Wood, MA | 1 |
| Höltgen, R; Wieczorek, M | 1 |
| Goyal, R; Knight, BP; Man, KC; Morady, F; Souza, J; Strickberger, A; Zivin, A | 1 |
| Chauvel, C; David, D; Guize, L; Lazarus, A; Le Heuzey, JY; Leneveut-Ledoux, L; Pellerin, D; Piot, O | 1 |
| Al-Nimri, M; Cheng, J; Dorostkar, P; Glatter, KA; Lee, RJ; Lesh, MD; Modin, G; Saxon, LA; Scheinman, MM; Talwar, S | 1 |
| Asanuma, H; Hori, M; Kitakaze, M; Koretsune, Y; Kuzuya, T; Minamino, T; Ueda, Y | 1 |
| Chiu, C; Gilljam, T; Gow, R; Hamilton, R; Jaeggi, E | 1 |
| Haft, JI; Khalighi, K | 1 |
| Cook, JR; Corbisiero, R; Fitzgerald, TF; Kabell, G; Kirchhoffer, JB | 1 |
| Gutierrez, J; Lapuerta, JA; Raviña, T | 1 |
| Fisher, JD; Kaplan, AV; Kaplan, IV | 1 |
| Kanmatsuse, K; Kojima, T; Kondo, K; Kunimoto, S; Nakai, T; Ozawa, Y; Saito, S; Watanabe, I | 1 |
| Grönefeld, G; Hohnloser, SH; Israel, C; Klingenheben, T | 1 |
| Bosch, RF; Drescher, S; Kühlkamp, V; Mewis, C | 1 |
| Chang, MS; Chen, SA; Chen, YJ; Lin, CI | 1 |
| Trohman, RG | 1 |
| Furusawa, Y; Nakaya, H; Ogura, T; Tamagawa, M; Uemura, H | 1 |
| Gibbons, RJ; Hart, CY; Hodge, DO; Miller, TD | 1 |
| Haynes, BE | 1 |
| Sternbach, GL | 1 |
| Accardi, AJ; Holmes, JF; Miller, R | 1 |
| Chrysostomakis, SI; Igoumenidis, NE; Kalebubas, MD; Kanoupakis, EM; Kochiadakis, GE; Simantirakis, EN; Skalidis, EI; Vardas, PE | 1 |
| Zaza, A | 1 |
| Martinez-Lopez, JI | 1 |
| Camm, AJ; Debbas, N; Garratt, C; Nunain, SO; Paul, V; Ward, DE | 1 |
| Belardinelli, L; Curtis, AB; Epstein, ML; Keim, S; Lerman, BB; Staples, ED | 1 |
| Damiano, R; Ellenbogen, KA; Rogers, R | 1 |
| Meurer, MK | 1 |
| Camm, AJ; Garratt, CJ; Griffith, MJ; O'Nunain, S; Ward, DE | 1 |
| Camm, AJ; Griffith, MJ; Linker, NJ; Ward, DE | 1 |
21 review(s) available for adenosine and Auricular Fibrillation
| Article | Year |
|---|---|
Supraventricular tachydysrhythmias in the emergency department.
Topics: Adenosine; Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Atrial Fibrillation; Calcium Channel Blockers; Carotid Sinus; Diagnosis, Differential; Electrocardiography; Emergency Medicine; Emergency Service, Hospital; Female; Humans; Male; Massage; Middle Aged; Practice Guidelines as Topic; Pregnancy; Tachycardia, Sinoatrial Nodal Reentry; Tachycardia, Sinus; Tachycardia, Supraventricular; Young Adult | 2020 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Role of adenosine-guided pulmonary vein isolation in patients undergoing catheter ablation for atrial fibrillation: a meta-analysis.
Topics: Adenosine; Atrial Fibrillation; Catheter Ablation; Disease-Free Survival; Evidence-Based Medicine; Female; Heart Conduction System; Humans; Male; Middle Aged; Prevalence; Pulmonary Veins; Risk Factors; Survival Rate; Treatment Outcome | 2017 |
Impact of targeting adenosine-induced transient venous reconnection in patients undergoing pulmonary vein isolation for atrial fibrillation: a meta-analysis of 3524 patients.
Topics: Adenosine; Adenosine Triphosphate; Adult; Aged; Atrial Fibrillation; Catheter Ablation; Electrophysiologic Techniques, Cardiac; Female; Humans; Male; Middle Aged; Odds Ratio; Predictive Value of Tests; Pulmonary Veins; Recurrence; Risk Factors; Time Factors; Treatment Outcome | 2017 |
Adenosine Testing After Atrial Fibrillation Ablation: Systematic Review and Meta-Analysis.
Topics: Adenosine; Atrial Fibrillation; Catheter Ablation; Heart Conduction System; Heart Rate; Humans; Postoperative Period; Vasodilator Agents | 2018 |
Targeting nonpulmonary vein triggers during atrial fibrillation ablation: is the game worth the candle?
Topics: Adenosine; Adrenergic beta-Agonists; Anti-Arrhythmia Agents; Atrial Appendage; Atrial Fibrillation; Catheter Ablation; Coronary Sinus; Humans; Isoproterenol; Pulmonary Veins; Recurrence; Vena Cava, Superior | 2018 |
Identification and Ablation of Dormant Conduction in Atrial Fibrillation Using Adenosine.
Topics: Adenosine; Adenosine Triphosphate; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Follow-Up Studies; Heart Conduction System; Humans; Observational Studies as Topic; Randomized Controlled Trials as Topic; Recurrence; Treatment Outcome | 2018 |
Adenosine triphosphate/adenosine guided pulmonary vein isolation does not improve the outcomes of ablation: a meta-analysis of randomized controlled trials.
Topics: Adenosine; Adenosine Triphosphate; Adult; Aged; Atrial Fibrillation; Catheter Ablation; Female; Humans; Male; Middle Aged; Pulmonary Veins; Randomized Controlled Trials as Topic; Recurrence; Treatment Outcome | 2018 |
The role of adenosine following pulmonary vein isolation in patients undergoing catheter ablation for atrial fibrillation: a systematic review.
Topics: Adenosine; Atrial Fibrillation; Cardiac Surgical Procedures; Catheter Ablation; Female; Humans; Male; Middle Aged; Pulmonary Veins; Treatment Outcome | 2013 |
Management of antiplatelet and anticoagulant therapy in patients with atrial fibrillation in the setting of acute coronary syndromes or percutaneous coronary interventions.
Topics: Acute Coronary Syndrome; Adenosine; Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Hemorrhage; Humans; Morpholines; Percutaneous Coronary Intervention; Piperazines; Platelet Aggregation Inhibitors; Postoperative Complications; Prasugrel Hydrochloride; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Thrombosis; Ticagrelor | 2014 |
Contemporary challenges of catheter ablation for atrial fibrillation.
Topics: Adenosine; Atrial Fibrillation; Catheter Ablation; Electrophysiologic Techniques, Cardiac; Fibrosis; Heart Atria; Humans; Patient Selection; Pulmonary Veins; Treatment Outcome | 2014 |
Concomitant Isolation of the Pulmonary Veins and Posterior Wall Using a Box Lesion Set in a Patient with Persistent Atrial Fibrillation and Variant Pulmonary Venous Anatomy.
Topics: Adenosine; Atrial Fibrillation; Catheter Ablation; Electrocardiography; Humans; Male; Middle Aged; Pulmonary Veins | 2016 |
Adenosine-guided pulmonary vein isolation versus conventional pulmonary vein isolation in patients undergoing atrial fibrillation ablation: An updated meta-analysis.
Topics: Adenosine; Atrial Fibrillation; Case-Control Studies; Catheter Ablation; Female; Follow-Up Studies; Humans; Male; Pulmonary Veins; Risk Assessment; Survival Rate; Treatment Outcome | 2017 |
The role of adenosine challenge in catheter ablation for atrial fibrillation: A systematic review and meta-analysis.
Topics: Adenosine; Atrial Fibrillation; Catheter Ablation; Cryosurgery; Humans; Percutaneous Coronary Intervention; Randomized Controlled Trials as Topic | 2017 |
CVT-510: a selective A1 adenosine receptor agonist.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Blood Pressure; Furans; Heart Rate; Humans; Receptor, Adenosine A1; Tachycardia, Supraventricular | 2003 |
Partial A(1) adenosine receptor agonists from a molecular perspective and their potential use as chronic ventricular rate control agents during atrial fibrillation (AF).
Topics: Adenosine; Adenosine A1 Receptor Agonists; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Entropy; Guanosine 5'-O-(3-Thiotriphosphate); Heart Rate; Humans; Ligands; Protein Conformation; Receptor, Adenosine A1; Receptors, G-Protein-Coupled; Structure-Activity Relationship | 2004 |
New antiarrhythmic treatment of atrial fibrillation.
Topics: Adenosine; Adenosine A1 Receptor Antagonists; Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Benzofurans; Biphenyl Compounds; Bridged Bicyclo Compounds, Heterocyclic; Carbazoles; Carvedilol; Cyclopropanes; Dronedarone; Fatty Acids, Omega-3; Furans; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Oligopeptides; Organic Chemicals; Peptidyl-Dipeptidase A; Potassium Channel Blockers; Propanolamines; Purinergic P1 Receptor Agonists | 2007 |
Adenosine-induced atrial fibrillation during pharmacologic stress testing: report of eight cases and review of the literature.
Topics: Adenosine; Aged; Atrial Fibrillation; Exercise Test; Female; Humans; Male; Middle Aged | 2008 |
Adenosine-induced atrial pro-arrhythmia in children.
Topics: Adenosine; Adolescent; Atrial Fibrillation; Atrial Flutter; Electrocardiography; Female; Humans; Infant, Newborn; Male; Tachycardia, Supraventricular; Wolff-Parkinson-White Syndrome | 1999 |
Supraventricular tachycardia: implications for the intensivist.
Topics: Adenosine; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Electrocardiography; Electrophysiologic Techniques, Cardiac; Humans; Sulfonamides; Tachycardia, Atrioventricular Nodal Reentry; Tachycardia, Supraventricular; Verapamil; Wolff-Parkinson-White Syndrome | 2000 |
CVT-510 (CV Therapeutics).
Topics: Adenosine; Animals; Atrial Fibrillation; Clinical Trials as Topic; Furans; Humans; Purinergic P1 Receptor Agonists; Receptors, Purinergic P1; Tachycardia, Ventricular; Technology, Pharmaceutical | 2002 |
39 trial(s) available for adenosine and Auricular Fibrillation
| Article | Year |
|---|---|
Acute efficacy of contiguous versus temporally discontiguous point-by-point radiofrequency pulmonary vein isolation in patients with paroxysmal atrial fibrillation: a randomized study.
Topics: Adenosine; Atrial Fibrillation; Catheter Ablation; Female; Humans; Male; Pulmonary Veins; Recurrence; Treatment Outcome | 2022 |
A Randomized Trial of High vs Standard Power Radiofrequency Ablation for Pulmonary Vein Isolation: SHORT-AF.
Topics: Adenosine; Aged; Atrial Fibrillation; Catheter Ablation; Female; Humans; Male; Pulmonary Veins; Treatment Outcome | 2023 |
Prevalence and clinical impact of spontaneous and adenosine-induced pulmonary vein reconduction in the Contact-Force vs. Cryoballoon Atrial Fibrillation Ablation (CIRCA-DOSE) study.
Topics: Adenosine; Atrial Fibrillation; Cryosurgery; Female; Follow-Up Studies; Heart Conduction System; Humans; Male; Middle Aged; Prevalence; Prospective Studies; Pulmonary Veins; Single-Blind Method; Vascular Remodeling; Vasodilator Agents | 2020 |
High Predictive Value of Adenosine Provocation in Predicting Atrial Fibrillation Recurrence After Pulmonary Vein Isolation With Visually Guided Laser Balloon Compared With Radiofrequency Ablation.
Topics: Action Potentials; Adenosine; Aged; Atrial Fibrillation; Catheter Ablation; Electrocardiography, Ambulatory; Electrophysiologic Techniques, Cardiac; Female; Germany; Heart Rate; Humans; Laser Therapy; Male; Middle Aged; Predictive Value of Tests; Pulmonary Veins; Recurrence; Reoperation; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome | 2020 |
General anesthesia or conscious sedation in paroxysmal atrial fibrillation catheter ablation.
Topics: Adenosine; Anesthesia, General; Atrial Fibrillation; Catheter Ablation; Conscious Sedation; Humans; Treatment Outcome | 2021 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Impact of adenosine on mechanisms sustaining persistent atrial fibrillation: Analysis of contact electrograms and non-invasive ECGI mapping data.
Topics: Adenosine; Atrial Fibrillation; Electrocardiography; Female; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Multivariate Analysis; Phenotype | 2021 |
Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.
Topics: Adenosine; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Dabigatran; Drug Therapy, Combination; Female; Hemorrhage; Humans; Incidence; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Risk; Ticagrelor; Ticlopidine; Warfarin | 2017 |
Pace-capture-guided ablation after contact-force-guided pulmonary vein isolation: results of the randomized controlled DRAGON trial.
Topics: Adenosine; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Electrocardiography, Ambulatory; Female; Humans; Male; Middle Aged; Pulmonary Veins; Treatment Outcome | 2018 |
A RAndomized Trial to compare the acute reconnection after pulmonary vein ISolation with Laser-BalloON versus radiofrequency Ablation: RATISBONA trial.
Topics: Action Potentials; Adenosine; Aged; Atrial Fibrillation; Cardiac Catheters; Catheter Ablation; Electrophysiologic Techniques, Cardiac; Female; Heart Rate; Humans; Laser Therapy; Male; Middle Aged; Pulmonary Veins; Recurrence; Risk Factors; Time Factors; Treatment Outcome | 2018 |
Is adenosine useful for the identification of atrial fibrillation triggers?
Topics: Action Potentials; Adenosine; Adrenergic beta-Agonists; Aged; Atrial Fibrillation; Catheter Ablation; Coronary Sinus; Electrophysiologic Techniques, Cardiac; Female; Heart Rate; Humans; Isoproterenol; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Pulmonary Veins; Purinergic P1 Receptor Agonists; Reproducibility of Results | 2019 |
Impact of low-dose dipyridamole injection on adenosine test after pulmonary vein isolation.
Topics: Adenosine; Aged; Atrial Fibrillation; Dipyridamole; Dose-Response Relationship, Drug; Drug Interactions; Female; Humans; Injections, Intravenous; Male; Pulmonary Veins; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome; Vasodilator Agents | 2013 |
Corticosteroid use during pulmonary vein isolation is associated with a higher prevalence of dormant pulmonary vein conduction.
Topics: Adenosine; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Electric Conductivity; Female; Heart Conduction System; Humans; Hydrocortisone; Male; Middle Aged; Prevalence; Prospective Studies; Pulmonary Veins; Recurrence | 2013 |
Beta-blockade and A1-adenosine receptor agonist effects on atrial fibrillatory rate and atrioventricular conduction in patients with atrial fibrillation.
Topics: Adenosine; Administration, Intravenous; Adrenergic beta-1 Receptor Antagonists; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrioventricular Node; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electrocardiography; Female; Furans; Heart Rate; Humans; Male; Middle Aged; Propanolamines; Purinergic P1 Receptor Agonists; Time Factors; Treatment Outcome | 2014 |
Administration of isoproterenol and adenosine to guide supplemental ablation after pulmonary vein antrum isolation.
Topics: Adenosine; Aged; Atrial Fibrillation; Drug Administration Schedule; Electrocardiography; Electrophysiologic Techniques, Cardiac; Female; Humans; Infusions, Intravenous; Injections, Intravenous; Isoproterenol; Male; Middle Aged; Patient Selection; Predictive Value of Tests; Prospective Studies; Pulmonary Veins; Recurrence; Reoperation; Texas; Treatment Outcome | 2013 |
Rationale and design of MANJUSRI trial: a randomized, open-label, active-controlled multicenter study to evaluate the safety of combined therapy with ticagrelor and warfarin in AF subjects after PCI-eS.
Topics: Adenosine; Adolescent; Adult; Aged; Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Drug-Eluting Stents; Female; Fibrinolytic Agents; Hemorrhage; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Prospective Studies; Research Design; Ticagrelor; Ticlopidine; Warfarin; Young Adult | 2015 |
Noninvasive Assessment of Atrioventricular Nodal Function: Effect of Rate-Control Drugs during Atrial Fibrillation.
Topics: Adenosine; Adrenergic beta-1 Receptor Antagonists; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrioventricular Node; Female; Furans; Humans; Male; Middle Aged; Propanolamines; Purinergic P1 Receptor Agonists | 2015 |
Rationale and design of the RT-AF study: Combination of rivaroxaban and ticagrelor in patients with atrial fibrillation and coronary artery disease undergoing percutaneous coronary intervention.
Topics: Adenosine; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Artery Disease; Drug Therapy, Combination; Hemorrhage; Humans; Percutaneous Coronary Intervention; Research Design; Rivaroxaban; Ticagrelor; Ticlopidine; Warfarin | 2015 |
Loss of Pace Capture on the Ablation Line During Pulmonary Vein Isolation versus "Dormant Conduction": Is Adenosine Expendable?
Topics: Adenosine; Atrial Fibrillation; Catheter Ablation; Electrocardiography; Female; Heart Conduction System; Humans; Male; Middle Aged; Monitoring, Intraoperative; Pulmonary Veins; Recurrence; Treatment Outcome | 2015 |
Adenosine-guided pulmonary vein isolation for the treatment of paroxysmal atrial fibrillation: an international, multicentre, randomised superiority trial.
Topics: Adenosine; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Female; Humans; Male; Middle Aged; Operative Time; Proportional Hazards Models; Pulmonary Veins; Secondary Prevention; Treatment Outcome | 2015 |
Arrhythmia Termination Versus Elimination of Dormant Pulmonary Vein Conduction as a Procedural End Point of Catheter Ablation for Paroxysmal Atrial Fibrillation: A Prospective Randomized Trial.
Topics: Adenosine; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Electrocardiography; Endpoint Determination; Female; Humans; Male; Middle Aged; Prospective Studies; Pulmonary Veins; Recurrence; Treatment Outcome | 2015 |
Role of adenosine after antral pulmonary vein isolation of paroxysmal atrial fibrillation: A randomized controlled trial.
Topics: Adenosine; Aged; Atrial Fibrillation; Cardiovascular Agents; Catheter Ablation; Female; Humans; Intraoperative Care; Isoproterenol; Male; Middle Aged; Postoperative Complications; Pulmonary Veins; Recurrence; Treatment Outcome | 2016 |
Achievement of successful pulmonary vein isolation: methods of adenosine testing and incremental benefit of exit block.
Topics: Adenosine; Atrial Fibrillation; Catheter Ablation; Dose-Response Relationship, Drug; Electrocardiography; Female; Humans; Male; Middle Aged; Monitoring, Intraoperative; Pulmonary Veins; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome; Vasodilator Agents | 2016 |
Wall thickness of the pulmonary vein-left atrial junction rather than electrical information as the major determinant of dormant conduction after contact force-guided pulmonary vein isolation.
Topics: Adenosine; Atrial Fibrillation; Catheter Ablation; Electrocardiography; Female; Heart Atria; Humans; Male; Middle Aged; Monitoring, Intraoperative; Organ Size; Pulmonary Veins; Stress, Mechanical; Vasodilator Agents | 2016 |
Dose-dependent pulmonary vein reconnection in response to adenosine: relevance of atrioventricular block during infusion.
Topics: Adenosine; Aged; Atrial Fibrillation; Atrioventricular Block; Dose-Response Relationship, Drug; Electrocardiography; Female; Humans; Infusions, Parenteral; Male; Pulmonary Veins; Reproducibility of Results; Sensitivity and Specificity; Vasodilator Agents | 2016 |
Determining the Optimal Dose of Adenosine for Unmasking Dormant Pulmonary Vein Conduction Following Atrial Fibrillation Ablation: Electrophysiological and Hemodynamic Assessment. DORMANT-AF Study.
Topics: Action Potentials; Adenosine; Aged; Atrial Fibrillation; Atrioventricular Block; Blood Pressure; Cardiac Pacing, Artificial; Catheter Ablation; Electrophysiologic Techniques, Cardiac; Female; Heart Rate; Humans; Male; Middle Aged; Predictive Value of Tests; Pulmonary Veins; Treatment Outcome; Victoria | 2017 |
Adenosine administration during hybrid atrial fibrillation ablation to test dormant pulmonary vein conduction.
Topics: Adenosine; Adult; Aged; Atrial Fibrillation; Catheter Ablation; Electrocardiography; Female; Heart Conduction System; Humans; Male; Middle Aged; Monitoring, Intraoperative; Pulmonary Veins; Treatment Outcome | 2017 |
A new approach for contrast-enhanced X-ray imaging of the left atrium and pulmonary veins for atrial fibrillation ablation: rotational angiography during adenosine-induced asystole.
Topics: Adenosine; Angiography; Atrial Fibrillation; Catheter Ablation; Contrast Media; Heart Arrest; Heart Atria; Heart Conduction System; Humans; Iopamidol; Male; Middle Aged; Pulmonary Veins; Radiography, Interventional; Rotation; Surgery, Computer-Assisted; Tomography, X-Ray Computed; Treatment Outcome; Vasodilator Agents | 2009 |
Early detection of pulmonary vein reconnection after isolation in patients with paroxysmal atrial fibrillation: a comparison of ATP-induction and reassessment at 30 minutes postisolation.
Topics: Adenosine; Adenosine Triphosphate; Atrial Fibrillation; Electrocardiography; Female; Humans; Male; Middle Aged; Reproducibility of Results; Secondary Prevention; Sensitivity and Specificity; Treatment Failure; Vasodilator Agents | 2009 |
Transient atriovenous reconnection induced by adenosine after successful pulmonary vein isolation with the cryothermal energy balloon.
Topics: Adenosine; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrioventricular Node; Catheter Ablation; Cryosurgery; Electrocardiography; Female; Heart Conduction System; Humans; Male; Middle Aged; Prognosis; Pulmonary Veins; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2009 |
Acute electrical isolation is a necessary but insufficient endpoint for achieving durable PV isolation: the importance of closing the visual gap.
Topics: Adenosine; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Edema; Electrophysiologic Techniques, Cardiac; Female; Heart Conduction System; Humans; Intraoperative Period; Male; Middle Aged; Postoperative Complications; Predictive Value of Tests; Pulmonary Veins | 2012 |
Time course of adenosine-induced pulmonary vein reconnection after isolation: implications for mechanism of dormant conduction.
Topics: Adenosine; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Electrocardiography; Female; Humans; Male; Middle Aged; Pulmonary Veins; Treatment Outcome | 2012 |
Adenosine instead of supranormal potassium in cardioplegia: it is safe, efficient, and reduces the incidence of postoperative atrial fibrillation. A randomized clinical trial.
Topics: Adenosine; Atrial Fibrillation; Biomarkers; Cardioplegic Solutions; Chi-Square Distribution; Coronary Artery Bypass; Creatine Kinase, MB Form; Crystalloid Solutions; Female; Heart Arrest, Induced; Hemodynamics; Humans; Incidence; Isotonic Solutions; Male; Middle Aged; Postoperative Complications; Potassium; Time Factors; Treatment Outcome; Troponin T | 2013 |
Results from late-breaking clinical trial sessions at the American College of Cardiology 51st Annual Scientific Session.
Topics: Adenosine; Angioplasty, Balloon, Coronary; Anti-Arrhythmia Agents; Antihypertensive Agents; Atherectomy, Coronary; Atrial Fibrillation; Azithromycin; Chlamydophila Infections; Coronary Disease; Defibrillators, Implantable; Double-Blind Method; Eplerenone; Heart Failure; Heart Transplantation; Heart-Assist Devices; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertrophy, Left Ventricular; Myocardial Reperfusion; Pyridines; Radiology, Interventional; Spironolactone; Stents; Thiazepines; Thrombolytic Therapy | 2002 |
Role of endogenous adenosine in atrial fibrillation after coronary artery bypass graft.
Topics: Adenosine; Aged; Atrial Fibrillation; Coronary Artery Bypass; Double-Blind Method; Electrocardiography; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Phosphodiesterase Inhibitors; Prospective Studies; Theophylline | 2004 |
Mechanisms underlying sustained firing from pulmonary veins: evidence from pacing maneuvers and pharmacological manipulation.
Topics: Adenosine; Atrial Fibrillation; Cardiac Pacing, Artificial; Female; Humans; Isoproterenol; Male; Middle Aged; Pulmonary Veins | 2004 |
Intravenous adenosine as first-line prehospital management of narrow-complex tachycardias by EMS personnel without direct physician control.
Topics: Adenosine; Adolescent; Adult; Aged; Aged, 80 and over; Atrial Fibrillation; Clinical Protocols; Electrocardiography; Emergency Medical Services; Female; Humans; Injections, Intravenous; Male; Middle Aged; Prospective Studies; Tachycardia, Paroxysmal; Tachycardia, Supraventricular | 1995 |
Effects of a selective A1-adenosine receptor agonist on heart rate and heart rate variability during permanent atrial fibrillation.
Topics: Adenosine; Anti-Arrhythmia Agents; Atrial Fibrillation; Double-Blind Method; Electrocardiography, Ambulatory; Exercise Test; Female; Heart Rate; Humans; Male; Middle Aged; Signal Processing, Computer-Assisted | 1998 |
Enhanced diagnosis of narrow complex tachycardias with increased electrocardiograph speed.
Topics: Adenosine; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Diagnosis, Differential; Electrocardiography; Humans; Prospective Studies; Tachycardia; Tachycardia, Sinus; Tachycardia, Supraventricular; Time Factors | 2002 |
171 other study(ies) available for adenosine and Auricular Fibrillation
| Article | Year |
|---|---|
Adenosine revives catheter-induced mechanical blocks in radiofrequency ablation.
Topics: Adenosine; Atrial Fibrillation; Catheter Ablation; Catheters; Humans; Pulmonary Veins; Treatment Outcome; Vena Cava, Superior | 2021 |
Vein of Marshall alcohol ablation for dormant pulmonary vein conduction: A case report.
Topics: Adenosine; Atrial Fibrillation; Catheter Ablation; Heart Rate; Humans; Pulmonary Veins; Treatment Outcome | 2022 |
Impact of Adenosine on Wavefront Propagation in Persistent Atrial Fibrillation: Insights From Global Noncontact Charge Density Mapping of the Left Atrium.
Topics: Adenosine; Atrial Fibrillation; Catheter Ablation; Electrophysiologic Techniques, Cardiac; Heart Atria; Heart Rate; Humans; Pulmonary Veins; Treatment Outcome | 2022 |
An Evaluation of Prehospital Adenosine Use.
Topics: Adenosine; Atrial Fibrillation; Child; Cross-Sectional Studies; Emergency Medical Services; Humans; Prospective Studies; Reproducibility of Results; Retrospective Studies; Tachycardia, Supraventricular | 2023 |
PolarX Cryoballoon metrics predicting successful pulmonary vein isolation: targets for ablation of atrial fibrillation.
Topics: Adenosine; Atrial Fibrillation; Benchmarking; Catheter Ablation; Cryosurgery; Humans; Prospective Studies; Pulmonary Veins; Recurrence; Time Factors; Treatment Outcome | 2022 |
Long-term outcome of adenosine-induced atrial fibrillation after atrial fibrillation ablation: A propensity score matching analysis.
Topics: Adenosine; Adenosine Triphosphate; Atrial Fibrillation; Catheter Ablation; Humans; Propensity Score; Pulmonary Veins; Recurrence; Reproducibility of Results; Treatment Outcome | 2022 |
Assessment of Intracoronary Adenosine-Induced Hyperemia in Patients with Atrial Fibrillation in Comparison with Patients in Sinus Rhythm.
Topics: Adenosine; Atrial Fibrillation; Coronary Angiography; Coronary Stenosis; Coronary Vessels; Fibrinolytic Agents; Fractional Flow Reserve, Myocardial; Humans; Hyperemia; Reproducibility of Results; Retrospective Studies; Vasodilator Agents | 2022 |
Impact of high frequency stimulation to confirm a complete box isolation in catheter ablation of non-paroxysmal atrial fibrillation.
Topics: Adenosine; Adenosine Triphosphate; Atrial Fibrillation; Catheter Ablation; Humans; Pulmonary Veins; Recurrence; Treatment Outcome | 2022 |
Increased Density of Endogenous Adenosine A
Topics: Adenosine; Animals; Atrial Fibrillation; Heart Atria; Humans; Leukocytes, Mononuclear; Myocytes, Cardiac; Receptor, Adenosine A2A; Swine | 2023 |
Optimization of superior vena cava isolation with aid of ablation index guidance.
Topics: Adenosine; Atrial Fibrillation; Catheter Ablation; Heart Atria; Heart Rate; Humans; Pulmonary Veins; Treatment Outcome; Vena Cava, Superior | 2023 |
The diagnostic and therapeutic challenge of atrial flutter in children: a case report.
Topics: Adenosine; Adult; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Child; Humans; Male; Tachycardia, Supraventricular | 2023 |
[Intracoronary adenosine induced-atrial fibrillation during fractional flow reserve evaluation].
Topics: Adenosine; Aged; Atrial Fibrillation; Coronary Vessels; Diagnostic Techniques and Procedures; Fractional Flow Reserve, Myocardial; Humans; Injections, Intra-Arterial; Male | 2019 |
Combined single-session cardiovascular magnetic resonance: stress perfusion and three-dimensional pulmonary vein angiography for stratification of atrial fibrillation patients with chest pain syndromes prior to catheter ablation.
Topics: Adenosine; Aged; Angiography; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Chest Pain; Coronary Angiography; Exercise Test; Female; Humans; Imaging, Three-Dimensional; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Myocardial Ischemia; Myocardial Perfusion Imaging; Preoperative Care; Pulmonary Veins; Risk Assessment | 2019 |
Pulmonary vein antral isolation causes depolarization of vein sleeves: Implications for the assessment of isolation.
Topics: Adenosine; Aged; Atrial Fibrillation; Catheter Ablation; Electrophysiologic Techniques, Cardiac; Female; Humans; Male; Middle Aged; Pulmonary Veins; Retrospective Studies | 2020 |
The low acute effectiveness of a high-power short duration radiofrequency current application technique in pulmonary vein isolation for atrial fibrillation.
Topics: Adenosine; Atrial Fibrillation; Catheter Ablation; Humans; Pulmonary Veins; Recurrence; Treatment Outcome | 2021 |
Adenosine usage during AF ablation in Europe and selected long-term findings from the ESC-EHRA EORP Atrial Fibrillation Ablation Long-Term registry.
Topics: Adenosine; Atrial Fibrillation; Catheter Ablation; Humans; Pulmonary Veins; Recurrence; Registries; Treatment Outcome | 2021 |
Catheter ablation of a latent accessory pathway under continuous infusion of adenosine: A case report.
Topics: Accessory Atrioventricular Bundle; Adenosine; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Humans; Infusions, Intra-Arterial; Male | 2020 |
Rate-dependent pacing failure after pacemaker implantation: Novel insights into the mechanism of using adenosine.
Topics: Adenosine; Aged, 80 and over; Atrial Fibrillation; Bradycardia; Cardiac Pacing, Artificial; Electrocardiography; Female; Humans; Pacemaker, Artificial; Sick Sinus Syndrome | 2020 |
Efficacy of isoproterenol in the evaluation of dormant conduction and arrhythmogenic foci identification in atrial fibrillation ablation.
Topics: Action Potentials; Adenosine; Adrenergic beta-Agonists; Aged; Atrial Fibrillation; Catheter Ablation; Cryosurgery; Electrophysiologic Techniques, Cardiac; Female; Heart Rate; Humans; Isoproterenol; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Pulmonary Veins; Purinergic P1 Receptor Agonists; Recurrence; Treatment Outcome | 2020 |
Unmasking Arrhythmogenic Hubs of Reentry Driving Persistent Atrial Fibrillation for Patient-Specific Treatment.
Topics: Adenosine; Adult; Atrial Fibrillation; Female; Heart; Heart Atria; Humans; Imaging, Three-Dimensional; Male; Microelectrodes; Middle Aged; Myocardium; Voltage-Sensitive Dye Imaging | 2020 |
Short P-Wave Duration is a Marker of Higher Rate of Atrial Fibrillation Recurrences after Pulmonary Vein Isolation: New Insights into the Pathophysiological Mechanisms Through Computer Simulations.
Topics: Action Potentials; Adenosine; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Computer Simulation; Electrocardiography; Female; Heart Conduction System; Humans; Male; Middle Aged; Postoperative Complications; Pulmonary Veins; Recurrence; Sodium Channels | 2021 |
Adenosine A
Topics: Adenosine; Adenosine Deaminase; Aged; Aged, 80 and over; Atrial Fibrillation; Atrial Remodeling; Female; Heart Atria; HEK293 Cells; Humans; Leukocytes, Mononuclear; Male; Microscopy, Confocal; Middle Aged; Receptor, Adenosine A2A; Up-Regulation | 2021 |
Dormant pulmonary vein conduction before ablation revealed by adenosine: evidence for intermittent venoatrial conduction?
Topics: Action Potentials; Adenosine; Atrial Fibrillation; Catheter Ablation; Electrophysiologic Techniques, Cardiac; Heart Rate; Humans; Male; Middle Aged; Predictive Value of Tests; Pulmonary Veins | 2017 |
The use of adenosine and ATP for the detection of dormant PV/LA conduction in atrial fibrillation ablation.
Topics: Adenosine; Adenosine Triphosphate; Atrial Fibrillation; Catheter Ablation; Humans; Pulmonary Veins | 2017 |
Electrophysiologic effects of adenosine versus ATP.
Topics: Adenosine; Adenosine Triphosphate; Atrial Fibrillation; Heart Rate; Humans; Pulmonary Veins | 2017 |
Comparison between local and systemic injection of adenosine for detecting dormant conduction after PV isolation.
Topics: Adenosine; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrioventricular Block; Catheter Ablation; Female; Hemodynamics; Humans; Male; Middle Aged; Pulmonary Veins | 2017 |
Demonstration of pulmonary vein exit block following pulmonary vein isolation: A novel use for adenosine.
Topics: Adenosine; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Humans; Pulmonary Veins; Retrospective Studies | 2018 |
Adenosine plasma level in patients with paroxysmal or persistent atrial fibrillation and normal heart during ablation procedure and/or cardioversion.
Topics: Adenosine; Aged; Atrial Fibrillation; Catheter Ablation; Electric Countershock; Female; Humans; Male; Middle Aged; Treatment Outcome | 2019 |
Long-term outcome of paroxysmal atrial fibrillation catheter ablation with and without pulmonary vein dormant conduction after adenosine challenge.
Topics: Adenosine; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Humans; Prognosis; Pulmonary Veins; Recurrence; Treatment Outcome | 2020 |
Down but not out-addressing the scourge of late pulmonary vein reconnection.
Topics: Adenosine; Atrial Fibrillation; Catheter Ablation; Heart Rate; Humans; Pulmonary Veins | 2019 |
Dormant Conduction: It Is Time to Wake Up.
Topics: Adenosine; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Conduction System Disease; Catheter Ablation; Coronary Sinus; Electrocardiography; Electrophysiologic Techniques, Cardiac; Humans; Male; Middle Aged; Pulmonary Veins | 2019 |
Adenosine test during confined pulmonary vein fibrillation: how to identify the dormant conduction?
Topics: Adenosine; Atrial Fibrillation; Catheter Ablation; Electrophysiologic Techniques, Cardiac; Heart Conduction System; Humans; Male; Middle Aged; Predictive Value of Tests; Pulmonary Veins; Tachycardia, Supraventricular | 2013 |
Electrocardiographic artefacts mimicking atrial tachycardia resulted in unnecessary diagnostic and therapeutic measures.
Topics: Adenosine; Adult; Artifacts; Atrial Fibrillation; Diagnostic Errors; Electrocardiography; Female; Humans; Predictive Value of Tests; Tachycardia, Supraventricular; Time Factors; Unnecessary Procedures | 2013 |
[Your patient needs antithrombotics, 2. What do the new substances offer? (interview by Dr. med. Peter Stiefelhagen)].
Topics: Adenosine; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cardiovascular Diseases; Clopidogrel; Dabigatran; Fibrinolytic Agents; Guideline Adherence; Humans; Morpholines; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Thromboembolism; Ticagrelor; Ticlopidine; Treatment Outcome | 2013 |
Adenosine-procaine cardioplegia and adenosine-lidocaine cardioplegia: Two sides of the same coin?
Topics: Adenosine; Atrial Fibrillation; Cardioplegic Solutions; Coronary Artery Bypass; Female; Heart Arrest, Induced; Humans; Male; Postoperative Complications; Potassium | 2013 |
Reply to the editor.
Topics: Adenosine; Atrial Fibrillation; Cardioplegic Solutions; Coronary Artery Bypass; Female; Heart Arrest, Induced; Humans; Male; Postoperative Complications; Potassium | 2013 |
Adenosine-induced atrial fibrillation: insights into mechanism.
Topics: Adenosine; Aged; Atrial Fibrillation; Body Surface Potential Mapping; Catheter Ablation; Electric Countershock; Electrocardiography; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Pulmonary Veins; Recurrence; Reoperation; Risk Assessment; Treatment Outcome | 2013 |
Residual conduction after pulmonary vein isolation with a circular multielectrode radiofrequency ablation catheter: the role of adenosine and orciprenalin during a prolonged observation time.
Topics: Adenosine; Aged; Atrial Fibrillation; Catheter Ablation; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Male; Metaproterenol; Middle Aged; Prospective Studies; Pulmonary Veins; Time Factors; Treatment Outcome | 2013 |
The hunt for nonpulmonary vein triggers and acute pulmonary vein reconnections.
Topics: Adenosine; Atrial Fibrillation; Electrophysiologic Techniques, Cardiac; Female; Humans; Isoproterenol; Male; Pulmonary Veins | 2013 |
Adenosine effect reinforced by dipyridamol: a better test to detect incomplete pulmonary vein isolation?
Topics: Adenosine; Atrial Fibrillation; Dipyridamole; Female; Humans; Male; Pulmonary Veins | 2013 |
Late re-conduction sites in the second session after pulmonary vein isolation using adenosine provocation for atrial fibrillation.
Topics: Action Potentials; Adenosine; Administration, Intravenous; Aged; Atrial Fibrillation; Cardiac Catheters; Catheter Ablation; Electrophysiologic Techniques, Cardiac; Equipment Design; Female; Humans; Japan; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Pulmonary Veins; Recurrence; Registries; Reoperation; Time Factors; Treatment Outcome | 2014 |
Adenosine reveals dormant conduction of an arrhythmogenic thoracic vein despite the absence of previous ablation.
Topics: Adenosine; Anti-Arrhythmia Agents; Atrial Fibrillation; Diagnosis, Differential; Electrocardiography; Heart Conduction System; Humans; Male; Middle Aged; Thorax; Vena Cava, Superior | 2014 |
Adenosine-induced pulmonary vein ectopy as a predictor of recurrent atrial fibrillation after pulmonary vein isolation.
Topics: Adenosine; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Electrophysiologic Techniques, Cardiac; Female; Heart Conduction System; Humans; Male; Middle Aged; Multivariate Analysis; Prognosis; Pulmonary Veins; Recurrence | 2013 |
Acute pulmonary vein reconnection is a predictor of atrial fibrillation recurrence following pulmonary vein isolation.
Topics: Adenosine; Atrial Fibrillation; Cardiotonic Agents; Catheter Ablation; Female; Heart Conduction System; Humans; Isoproterenol; Male; Middle Aged; Prognosis; Prospective Studies; Pulmonary Veins; Recurrence; Risk Factors; Treatment Outcome; Vasodilator Agents | 2014 |
Mechanisms of pulmonary vein reconnection after radiofrequency ablation of atrial fibrillation: the deterministic role of contact force and interlesion distance.
Topics: Adenosine; Aged; Atrial Fibrillation; Cardiac Catheterization; Cardiac Catheters; Catheter Ablation; Electrophysiologic Techniques, Cardiac; Equipment Design; Female; Humans; Male; Middle Aged; Prospective Studies; Pulmonary Veins; Recurrence; Time Factors; Transducers, Pressure; Treatment Outcome | 2014 |
Spontaneous and adenosine-induced pulmonary vein reconnection after cryoballoon ablation with the second-generation device.
Topics: Adenosine; Aged; Atrial Fibrillation; Cryosurgery; Equipment Design; Female; Humans; Male; Middle Aged; Predictive Value of Tests; Pulmonary Veins; Recurrence; Risk Factors; Time Factors; Treatment Outcome | 2014 |
Upregulation of adenosine A1 receptors facilitates sinoatrial node dysfunction in chronic canine heart failure by exacerbating nodal conduction abnormalities revealed by novel dual-sided intramural optical mapping.
Topics: Action Potentials; Adenosine; Adenosine A1 Receptor Antagonists; Animals; Atrial Fibrillation; Bradycardia; Cardiac Pacing, Artificial; Dogs; Dose-Response Relationship, Drug; Fibrosis; Heart Conduction System; Heart Failure; Receptor, Adenosine A1; Sinoatrial Node; Tachycardia; Theophylline; Up-Regulation; Voltage-Sensitive Dye Imaging; Xanthines | 2014 |
Adenosine testing after second-generation balloon devices (cryothermal and laser) mediated pulmonary vein ablation for atrial fibrillation.
Topics: Adenosine; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Cryosurgery; Electrocardiography; Female; Follow-Up Studies; Humans; Laser Therapy; Male; Middle Aged; Postoperative Complications; Pulmonary Veins; Treatment Outcome | 2014 |
Bradycardia-dependent conduction block into pulmonary vein after isolation.
Topics: Action Potentials; Adenosine; Aged; Atrial Fibrillation; Bradycardia; Cardiac Pacing, Artificial; Catheter Ablation; Electrophysiologic Techniques, Cardiac; Heart Block; Humans; Male; Predictive Value of Tests; Pulmonary Veins; Time Factors | 2014 |
Adenosine administration following pulmonary vein isolation: what is occurring?
Topics: Adenosine; Adult; Atrial Fibrillation; Electrocardiography; Heart Conduction System; Humans; Male; Pulmonary Veins; Tachycardia, Atrioventricular Nodal Reentry; Treatment Outcome; Vasodilator Agents | 2015 |
Mechanisms and clinical significance of adenosine-induced dormant accessory pathway conduction after catheter ablation.
Topics: Accessory Atrioventricular Bundle; Action Potentials; Adenosine; Adolescent; Adult; Aged; Atrial Fibrillation; Catheter Ablation; Electrophysiologic Techniques, Cardiac; Female; Humans; Logistic Models; Male; Middle Aged; Odds Ratio; Predictive Value of Tests; Pulmonary Veins; Recurrence; Retrospective Studies; Risk Factors; Treatment Outcome; Young Adult | 2014 |
Electrical connection between ipsilateral pulmonary veins: prevalence and implications for ablation and adenosine testing.
Topics: Adenosine; Anti-Arrhythmia Agents; Atrial Fibrillation; Body Surface Potential Mapping; Catheter Ablation; Follow-Up Studies; Heart Conduction System; Humans; Injections, Intravenous; Prospective Studies; Pulmonary Veins; Treatment Outcome | 2015 |
Concomitant use of warfarin and ticagrelor as an alternative to triple antithrombotic therapy after an acute coronary syndrome.
Topics: Acute Coronary Syndrome; Adenosine; Aged; Aged, 80 and over; Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Female; Fibrinolytic Agents; Hemorrhage; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Thrombosis; Ticagrelor; Ticlopidine; Treatment Outcome; Warfarin | 2015 |
Low contact force and force-time integral predict early recovery and dormant conduction revealed by adenosine after pulmonary vein isolation.
Topics: Adenosine; Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Cohort Studies; Female; Heart Conduction System; Humans; Male; Middle Aged; Prospective Studies; Pulmonary Veins; Single-Blind Method; Treatment Outcome | 2015 |
Limitations of dormant conduction as a predictor of atrial fibrillation recurrence and pulmonary vein reconnection after catheter ablation.
Topics: Adenosine; Atrial Fibrillation; Catheter Ablation; Echocardiography; Female; Heart Conduction System; Humans; Male; Middle Aged; Pulmonary Veins; Recurrence; Vasodilator Agents | 2015 |
Unmasking the dormant pulmonary vein conduction with adenosine administration after pulmonary vein isolation with laser energy.
Topics: Adenosine; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Female; Humans; Laser Therapy; Male; Middle Aged; Postoperative Complications; Pulmonary Veins; Treatment Outcome | 2015 |
Incidence and predictors of dormant conduction after cryoballoon ablation incorporating a 30-min waiting period.
Topics: Adenosine; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Cryosurgery; Electrocardiography, Ambulatory; Female; Heart Rate; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Postoperative Complications; Prognosis; Pulmonary Veins; Recurrence; Treatment Outcome | 2015 |
Adenosine testing after second-generation cryoballoon ablation (ATSCA) study improves clinical success rate for atrial fibrillation.
Topics: Adenosine; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Case-Control Studies; Cryosurgery; Female; Humans; Male; Middle Aged; Pulmonary Veins; Recurrence; Retrospective Studies; Treatment Outcome | 2015 |
Shortening of freezing cycles provides equal outcome to standard ablation procedure using second-generation 28 mm cryoballoon after 15-month follow-up.
Topics: Adenosine; Aged; Atrial Fibrillation; Cardiac Catheters; Cryosurgery; Disease-Free Survival; Electrocardiography, Ambulatory; Electrophysiologic Techniques, Cardiac; Equipment Design; Female; Humans; Male; Middle Aged; Predictive Value of Tests; Pulmonary Veins; Quality of Life; Recurrence; Registries; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome | 2016 |
The acute effects and follow-up after the visually guided laser balloon ablation for atrial fibrillation treatment.
Topics: Adenosine; Anti-Arrhythmia Agents; Atrial Fibrillation; Female; Humans; Laser Therapy; Male; Postoperative Complications; Pulmonary Veins | 2016 |
ADVICE on adenosine to improve atrial fibrillation ablation.
Topics: Adenosine; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Female; Humans; Male; Pulmonary Veins | 2015 |
Atrial fibrillation. Adenosine testing during catheter ablation of AF reduces recurrent atrial tachyarrhythmia.
Topics: Adenosine; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Female; Humans; Male; Pulmonary Veins | 2015 |
eComment. New onset atrial fibrillation induced by adenosine.
Topics: Adenosine; Atrial Fibrillation; Electrocardiography; Humans; Treatment Outcome | 2015 |
One drug, two outcomes after atrial fibrillation ablation: the situational irony of adenosine.
Topics: Adenosine; Atrial Fibrillation; Catheter Ablation; Heart Conduction System; Humans; Treatment Outcome | 2015 |
Unmasking right atrial fibrillation: A new indication of adenosine triphosphate test?
Topics: Adenosine; Adenosine Triphosphate; Atrial Fibrillation; Electrocardiography; Heart Atria; Heart Conduction System; Humans | 2016 |
Arrhythmias in 2015: Advances in drug, ablation, and device therapy for cardiac arrhythmias.
Topics: Adenosine; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Catheter Ablation; Defibrillators, Implantable; Digoxin; Evidence-Based Medicine; Heart Conduction System; Humans; Pacemaker, Artificial; Pulmonary Veins; Randomized Controlled Trials as Topic | 2016 |
One-year clinical outcome after ablation with a novel multipolar irrigated ablation catheter for treatment of atrial fibrillation: potential implications for clinical use.
Topics: Adenosine; Aged; Anticoagulants; Atrial Fibrillation; Catheter Ablation; Equipment Design; Equipment Failure Analysis; Female; Fluoroscopy; Follow-Up Studies; Humans; Male; Middle Aged; Operative Time; Prospective Studies; Pulmonary Veins; Treatment Outcome | 2016 |
Another side effect of ticagrelor: Atrial fibrillation.
Topics: Adenosine; Aged; Angina, Unstable; Atrial Fibrillation; Clopidogrel; Humans; Male; Ticagrelor; Ticlopidine; Treatment Outcome | 2016 |
Adenosine-Induced Atrial Fibrillation: Localized Reentrant Drivers in Lateral Right Atria due to Heterogeneous Expression of Adenosine A1 Receptors and GIRK4 Subunits in the Human Heart.
Topics: Adenosine; Adult; Aged; Atrial Fibrillation; Female; G Protein-Coupled Inwardly-Rectifying Potassium Channels; Gene Expression Regulation; Heart; Heart Atria; Heart Conduction System; Humans; Male; Middle Aged; Organ Culture Techniques; Positron Emission Tomography Computed Tomography; Receptor, Adenosine A1 | 2016 |
Adenosine and Atrial Tachycardia: Learning Before Burning?
Topics: Adenosine; Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Humans; Tachycardia, Supraventricular | 2016 |
Redefining the Blanking Period After Catheter Ablation for Paroxysmal Atrial Fibrillation: Insights From the ADVICE (Adenosine Following Pulmonary Vein Isolation to Target Dormant Conduction Elimination) Trial.
Topics: Adenosine; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Electrocardiography; Female; Humans; Male; Middle Aged; Monitoring, Ambulatory; Pulmonary Veins; Recurrence; Treatment Outcome | 2016 |
Time matters: adenosine testing immediately after pulmonary vein isolation does not substitute a waiting period.
Topics: Action Potentials; Adenosine; Aged; Atrial Fibrillation; Catheter Ablation; Electrophysiologic Techniques, Cardiac; Female; Heart Rate; Humans; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Pulmonary Veins; Recurrence; Reproducibility of Results; Risk Factors; Time Factors; Treatment Outcome | 2017 |
Letter by He Regarding Article, "Adenosine-Induced Atrial Fibrillation: Localized Reentrant Drivers in Lateral Right Atria Due to Heterogeneous Expression of Adenosine A1 Receptors and GIRK4 Subunits in the Human Heart".
Topics: Adenosine; Atrial Fibrillation; Heart Atria; Humans; Male; Receptor, Adenosine A1 | 2016 |
Response by Li et al to Letter Regarding Article, "Adenosine-Induced Atrial Fibrillation: Localized Reentrant Drivers in Lateral Right Atria Due to Heterogeneous Expression of Adenosine A1 Receptors and GIRK4 Subunits in the Human Heart".
Topics: Adenosine; Atrial Appendage; Atrial Fibrillation; Heart Atria; Humans; Receptor, Adenosine A1 | 2016 |
Transient Restoration of the Electrical Conduction Between the Left Atrium and Coronary Sinus Musculature.
Topics: Action Potentials; Adenosine; Aged; Atrial Fibrillation; Atrial Function, Left; Catheter Ablation; Coronary Sinus; Electrophysiologic Techniques, Cardiac; Female; Heart Atria; Heart Rate; Humans; Muscle, Smooth, Vascular; Pulmonary Veins; Treatment Outcome | 2017 |
Sinusal reversion of supraventricular tachyarrhythmias after propofol administration. A case series.
Topics: Adenosine; Adult; Aged; Amiodarone; Atrial Fibrillation; Atrial Flutter; Electric Countershock; Female; Heart Rate; Humans; Hypnotics and Sedatives; Male; Middle Aged; Propofol; Tachycardia, Supraventricular | 2017 |
Ticagrelor, but not clopidogrel active metabolite, displays antithrombotic properties in the left atrial endocardium.
Topics: Adenosine; Antithrombins; Atrial Appendage; Atrial Fibrillation; Clopidogrel; Endocardium; Heart Atria; Humans; Plasminogen Activator Inhibitor 1; Purinergic P2Y Receptor Antagonists; Thromboplastin; Ticagrelor; Ticlopidine; Tumor Necrosis Factor-alpha | 2017 |
Isolation of the posterior left atrium for patients with persistent atrial fibrillation: routine adenosine challenge for dormant posterior left atrial conduction improves long-term outcome.
Topics: Action Potentials; Adenosine; Aged; Atrial Fibrillation; Atrial Function, Left; Catheter Ablation; Disease-Free Survival; Electrocardiography, Ambulatory; Electrophysiologic Techniques, Cardiac; Female; Heart Atria; Heart Rate; Humans; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Pulmonary Veins; Recurrence; Time Factors; Treatment Outcome | 2017 |
Myocardial perfusion in nonischemic dilated cardiomyopathy with and without atrial fibrillation.
Topics: Adenosine; Adult; Atrial Fibrillation; Cardiomyopathy, Dilated; Coronary Circulation; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Oxygen Radioisotopes; Positron-Emission Tomography; Radiopharmaceuticals; Water | 2009 |
Beyond pulmonary vein isolation: the issue of reconduction.
Topics: Adenosine; Adenosine Triphosphate; Atrial Fibrillation; Electrocardiography; Female; Humans; Male; Middle Aged; Reproducibility of Results; Secondary Prevention; Sensitivity and Specificity; Treatment Failure; Vasodilator Agents | 2009 |
Left superior vena cava conduction to the left atrium unmasked by adenosine in a patient with paroxysmal atrial fibrillation during pulmonary vein isolation.
Topics: Adenosine; Aged; Atrial Fibrillation; Diagnosis, Differential; Electrocardiography; Female; Heart Atria; Heart Conduction System; Humans; Pulmonary Veins; Vasodilator Agents; Vena Cava, Superior | 2010 |
Adenosine-induced flow arrest to facilitate intracranial aneurysm clip ligation: dose-response data and safety profile.
Topics: Adenosine; Adult; Aged; Anesthesia, General; Anesthetics, Inhalation; Anesthetics, Intravenous; Atrial Fibrillation; Cardiovascular Diseases; Cerebrovascular Circulation; Dose-Response Relationship, Drug; Female; Humans; Intracranial Aneurysm; Ligation; Male; Middle Aged; Nervous System Diseases; Neurosurgical Procedures; Piperidines; Postoperative Complications; Propofol; Remifentanil; Vasodilator Agents | 2010 |
Dormant pulmonary vein conduction induced by adenosine in patients with atrial fibrillation who underwent catheter ablation.
Topics: Adenosine; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Female; Follow-Up Studies; Heart Conduction System; Humans; Male; Middle Aged; Pulmonary Veins; Treatment Outcome | 2011 |
Does adenosine response predict clinical recurrence of atrial fibrillation after pulmonary vein isolation?
Topics: Adenosine; Aged; Atrial Fibrillation; Catheter Ablation; Female; Follow-Up Studies; Humans; Male; Middle Aged; Predictive Value of Tests; Pulmonary Veins; Recurrence; Treatment Outcome | 2011 |
Unusual response of an accessory atrioventricular connection to adenosine.
Topics: Adenosine; Atrial Fibrillation; Atrioventricular Node; Humans; Male; Middle Aged | 2012 |
Sex differences in the electrophysiological characteristics of pulmonary veins and left atrium and their clinical implication in atrial fibrillation.
Topics: Acetylcholine; Action Potentials; Adenosine; Animals; Atrial Fibrillation; Autonomic Nervous System; Cardiotonic Agents; Disease Models, Animal; Electrophysiologic Techniques, Cardiac; Female; Heart Atria; Isoproterenol; Male; Pulmonary Veins; Rabbits; Sex Characteristics; Vasodilator Agents | 2011 |
Differential effectiveness of pharmacological strategies to reveal dormant pulmonary vein conduction: a clinical-experimental correlation.
Topics: Adenosine; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiotonic Agents; Catheter Ablation; Dogs; Drug Administration Schedule; Female; Heart Conduction System; Humans; Isoproterenol; Male; Middle Aged; Pulmonary Veins | 2011 |
Ablation: search and destroy dormant gaps awakened by adenosine.
Topics: Adenosine; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiotonic Agents; Female; Humans; Isoproterenol; Male; Pulmonary Veins | 2011 |
[Adenosine and proarrhythmia in patients with Wolf-Parkinson-White syndrome].
Topics: Adenosine; Atrial Fibrillation; Humans; Male; Wolff-Parkinson-White Syndrome; Young Adult | 2013 |
Impact of adenosine-provoked acute dormant pulmonary vein conduction on recurrence of atrial fibrillation.
Topics: Adenosine; Adenosine Triphosphate; Aged; Atrial Fibrillation; Catheter Ablation; Confidence Intervals; Electrocardiography; Female; Follow-Up Studies; Heart Conduction System; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neural Conduction; Predictive Value of Tests; Proportional Hazards Models; Pulmonary Veins; Recurrence; Stroke Volume; Treatment Outcome | 2012 |
PVI's inconvenient truths: lights out for dormant reconnection?
Topics: Adenosine; Atrial Fibrillation; Female; Humans; Male; Pulmonary Veins | 2012 |
Value of intraprocedural radiologic rotational angiography in atrial fibrillation ablation. Comparison with other imaging techniques.
Topics: Adenosine; Anti-Arrhythmia Agents; Atrial Fibrillation; Female; Heart; Heart Atria; Humans; Imaging, Three-Dimensional; Intraoperative Period; Magnetic Resonance Imaging, Interventional; Male; Middle Aged; Pulmonary Veins; Tomography, X-Ray Computed | 2012 |
Adenosine and atrial arrhythmias: exploring electrophysiological mechanisms in vivo.
Topics: Adenosine; Atrial Fibrillation; Catheter Ablation; Electrocardiography; Female; Humans; Male; Pulmonary Veins | 2012 |
Dual utility of adenosine during focal AF.
Topics: Adenosine; Adult; Atrial Fibrillation; Catheter Ablation; Electrocardiography; Electrophysiologic Techniques, Cardiac; Humans; Male; Predictive Value of Tests; Pulmonary Veins; Recurrence; Reoperation; Treatment Outcome | 2012 |
Dormant conduction revealed by adenosine to guide electrical isolation of the superior vena cava.
Topics: Adenosine; Atrial Appendage; Atrial Fibrillation; Cardiotonic Agents; Catheter Ablation; Heart Conduction System; Humans; Isoproterenol; Male; Phrenic Nerve; Vena Cava, Superior | 2012 |
Adenosine plus dipyridamole: a novel strategy to enhance adenosine-induced conduction recovery after pulmonary vein isolation.
Topics: Adenosine; Aged; Atrial Fibrillation; Catheter Ablation; Chi-Square Distribution; Dipyridamole; Electrocardiography; Electrophysiologic Techniques, Cardiac; Female; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Pulmonary Veins; Time Factors; Treatment Outcome | 2012 |
Differential effects of adenosine on pulmonary vein ectopy after pulmonary vein isolation: implications for arrhythmogenesis.
Topics: Adenosine; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Chi-Square Distribution; Electrocardiography; Female; Heart Rate; Humans; Injections, Intravenous; Male; Middle Aged; New York City; Predictive Value of Tests; Pulmonary Veins; Time Factors; Treatment Outcome | 2012 |
How country-specific should a country-specific cost-effectiveness analysis be?
Topics: Acute Coronary Syndrome; Adenosine; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Female; Humans; Male; Platelet Aggregation Inhibitors; Ticagrelor; Warfarin | 2013 |
High endogenous adenosine plasma concentration is associated with atrial fibrillation during cardiac surgery with cardiopulmonary bypass.
Topics: Adenosine; Aged; Aged, 80 and over; Atrial Fibrillation; Biomarkers; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Female; Humans; Male; Middle Aged; Prospective Studies | 2013 |
Mechanisms of human atrial fibrillation initiation: clinical and computational studies of repolarization restitution and activation latency.
Topics: Action Potentials; Adenosine; Adrenergic beta-Agonists; Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Calcium Channels, L-Type; Computer Simulation; Female; Heart Conduction System; Humans; Isoproterenol; Male; Middle Aged; Potassium Channels, Inwardly Rectifying; Reaction Time; Time Factors | 2012 |
Is it dormant pulmonary vein conduction?
Topics: Adenosine; Aged; Atrial Fibrillation; Diagnosis, Differential; Electrocardiography; Heart Conduction System; Humans; Male; Pulmonary Veins; Treatment Outcome | 2013 |
Clinical implication of adenosine test at repeat atrial fibrillation ablation procedure: the importance of detecting dormant thoracic vein conduction.
Topics: Adenosine; Aged; Atrial Fibrillation; Catheter Ablation; Electrocardiography; Electrophysiologic Techniques, Cardiac; Female; Heart Conduction System; Humans; Male; Middle Aged; Pulmonary Veins; Recurrence; Risk Factors; Thorax; Treatment Outcome; Veins; Vena Cava, Superior | 2012 |
Impact of radiofrequency characteristics on acute pulmonary vein reconnection and clinical outcome after PVAC ablation.
Topics: Adenosine; Aged; Atrial Fibrillation; Catheter Ablation; Disease-Free Survival; Electrophysiologic Techniques, Cardiac; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Predictive Value of Tests; Pulmonary Veins; Recurrence; Signal Processing, Computer-Assisted; Software; Time Factors; Treatment Outcome | 2013 |
Adenosine-induced atrial fibrillation during fractional flow reserve measurement.
Topics: Adenosine; Adult; Atrial Fibrillation; Coronary Angiography; Coronary Artery Disease; Follow-Up Studies; Fractional Flow Reserve, Myocardial; Humans; Infusions, Intra-Arterial; Male; Treatment Outcome; Vasodilator Agents | 2012 |
Clinical utility of adenosine-infusion test at a repeat atrial fibrillation ablation procedure.
Topics: Adenosine; Aged; Atrial Fibrillation; Catheter Ablation; Female; Heart Conduction System; Humans; Male; Middle Aged; Pulmonary Veins; Recurrence; Treatment Outcome; Vena Cava, Superior | 2013 |
Toward permanent pulmonary vein isolation: the use of adenosine to unmask dormant conduction.
Topics: Adenosine; Atrial Fibrillation; Catheter Ablation; Female; Heart Conduction System; Humans; Male; Pulmonary Veins; Vena Cava, Superior | 2013 |
[Transient atrial fibrillation induced by adenosine in a patient with atrial tachycardia].
Topics: Adenosine; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Female; Humans; Middle Aged; Tachycardia, Supraventricular; Ventricular Premature Complexes | 2002 |
Atrial premature beats in patients with focal atrial fibrillation: incidence at baseline and impact of provocative maneuvers.
Topics: Adenosine; Adrenergic Fibers; Atrial Fibrillation; Atrial Premature Complexes; Electrocardiography, Ambulatory; Electrophysiologic Techniques, Cardiac; Female; Humans; Male; Metaproterenol; Middle Aged; Propanolamines; Sodium Chloride; Vagus Nerve | 2002 |
Diadenosine-5-phosphate exerts A1-receptor-mediated proarrhythmic effects in rabbit atrial myocardium.
Topics: Acetylcholine; Adenosine; Adenosine A1 Receptor Antagonists; Animals; Atrial Fibrillation; Atrial Function; Dinucleoside Phosphates; Dipyridamole; Dose-Response Relationship, Drug; Electric Stimulation; Electrophysiology; Heart Atria; Heart Rate; Membrane Potentials; Myocytes, Cardiac; Patch-Clamp Techniques; Perfusion; Rabbits; Receptor, Adenosine A1; Refractory Period, Electrophysiological; Signal Transduction; Xanthines | 2003 |
Affinity and intrinsic efficacy (IE) of 5'-carbamoyl adenosine analogues for the A1 adenosine receptor--efforts towards the discovery of a chronic ventricular rate control agent for the treatment of atrial fibrillation (AF).
Topics: Adenosine; Animals; Atrial Fibrillation; Guinea Pigs; Heart Rate; Humans; In Vitro Techniques; Liver; Protein Binding; Rats; Receptor, Adenosine A1; Structure-Activity Relationship | 2004 |
[Adenosine-induced atrial instability].
Topics: Adenosine; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Female; Humans | 2004 |
The puzzle of pulmonary vein electrophysiology: the role of adenosine.
Topics: Adenosine; Atrial Fibrillation; Catheter Ablation; Electrophysiology; Humans; Pulmonary Veins | 2004 |
"Dormant" pulmonary vein conduction revealed by adenosine after ostial radiofrequency catheter ablation.
Topics: Adenosine; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Drug Resistance; Female; Heart Conduction System; Humans; Male; Middle Aged; Prospective Studies; Pulmonary Veins | 2004 |
Complete isolation of left atrium surrounding the pulmonary veins: new insights from the double-Lasso technique in paroxysmal atrial fibrillation.
Topics: Adenosine; Aged; Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Cardiac Catheterization; Catheter Ablation; Combined Modality Therapy; Coronary Disease; Electrocardiography; Female; Follow-Up Studies; Heart Conduction System; Humans; Hypertension; Male; Middle Aged; Phlebography; Postoperative Complications; Prospective Studies; Pulmonary Veins; Recurrence; Tachycardia; Treatment Outcome; Warfarin | 2004 |
Adenosine restores atrio-venous conduction after apparently successful ostial isolation of the pulmonary veins.
Topics: Adenosine; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Pulmonary Veins; Treatment Outcome | 2004 |
Life-threatening proarrhythmia in a patient with orthodromic atrioventricular tachycardia treated with low-dose adenosine.
Topics: Adenosine; Adult; Anti-Arrhythmia Agents; Atrial Fibrillation; Electric Countershock; Humans; Injections, Intravenous; Male; Severity of Illness Index; Tachycardia, Atrioventricular Nodal Reentry; Treatment Outcome | 2005 |
Response to pharmacological challenge of dissociated pulmonary vein rhythm.
Topics: Adenosine; Atrial Fibrillation; Female; Humans; Isoproterenol; Male; Middle Aged; Phenylephrine; Pulmonary Veins; Verapamil | 2005 |
Induction of atrial fibrillation after the routine use of adenosine.
Topics: Adenosine; Anti-Arrhythmia Agents; Atrial Fibrillation; Child; Humans; Male | 2006 |
[Inducibility of atrial arrhythmias after adenosine and isoproterenol infusion in patients referred for atrial fibrillation ablation].
Topics: Adenosine; Atrial Fibrillation; Catheter Ablation; Data Interpretation, Statistical; Electrophysiology; Follow-Up Studies; Humans; Isoproterenol; Time Factors; Treatment Outcome | 2006 |
Validation of the noncontact mapping system in the left atrium during permanent atrial fibrillation and sinus rhythm.
Topics: Adenosine; Adult; Atrial Fibrillation; Atrial Function, Left; Electrophysiologic Techniques, Cardiac; Female; Heart Block; Heart Rate; Humans; Male; Middle Aged; User-Computer Interface | 2006 |
Atrial fibrillation during adenosine pharmacologic stress testing.
Topics: Adenosine; Aged, 80 and over; Atrial Fibrillation; Electroencephalography; Exercise Test; Female; Humans; Middle Aged; Ventricular Dysfunction, Left | 2006 |
A case of a borderline-broad complex tachycardia.
Topics: Adenosine; Anti-Arrhythmia Agents; Atrial Fibrillation; Bundle-Branch Block; Carotid Sinus; Diagnosis, Differential; Electrocardiography; Emergency Treatment; Humans; Male; Massage; Middle Aged; Risk Factors; Tachycardia, Supraventricular; Tachycardia, Ventricular; Verapamil | 2006 |
Activation of inward rectifier potassium channels accelerates atrial fibrillation in humans: evidence for a reentrant mechanism.
Topics: Adenosine; Adult; Atrial Fibrillation; Catheter Ablation; Computer Simulation; Electrophysiology; Female; Heart Atria; Heart Conduction System; Humans; Male; Middle Aged; Potassium Channels, Inwardly Rectifying; Pulmonary Veins; Sinoatrial Node; Tachycardia, Paroxysmal | 2006 |
Interactions between two simultaneous tachycardias within an electrically isolated pulmonary vein.
Topics: Adenosine; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Humans; Male; Middle Aged; Pulmonary Veins; Tachycardia; Treatment Outcome | 2007 |
Reentry and atrial fibrillation.
Topics: Action Potentials; Adenosine; Atrial Fibrillation; Chronic Disease; Heart Atria; Heart Conduction System; Humans; Pulmonary Veins; Tachycardia, Paroxysmal | 2007 |
A novel finding--isolated Marshall's ligament rhythm after catheter ablation and reconnection of the Marshall's ligament with the left atrium after an adenosine bolus in one patient with atrial fibrillation.
Topics: Adenosine; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Heart Atria; Humans; Ligaments; Male; Pulmonary Veins | 2007 |
Quantifying activation frequency in atrial fibrillation to establish underlying mechanisms and ablation guidance.
Topics: Acetylcholine; Adenosine; Animals; Atrial Fibrillation; Body Surface Potential Mapping; Catheter Ablation; Dogs; Electrocardiography; Follow-Up Studies; Fourier Analysis; Heart Conduction System; Heart Rate; Humans; Imaging, Three-Dimensional; Sheep; Spectrum Analysis | 2007 |
Functional characterization of atrial electrograms in sinus rhythm delineates sites of parasympathetic innervation in patients with paroxysmal atrial fibrillation.
Topics: Adenosine; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Electrocardiography; Female; Humans; Male; Middle Aged; Models, Biological; Parasympathetic Nervous System; Retrospective Studies; Sensitivity and Specificity; Sinoatrial Node | 2007 |
Ultra rapid local activity in adenosine-induced atrial fibrillation.
Topics: Adenosine; Adult; Atrial Fibrillation; Electrocardiography; Humans; Male; Vasodilator Agents | 2008 |
Pre-excited atrial fibrillation triggered by intravenous adenosine: a commonly used drug with potentially life-threatening adverse effects.
Topics: Adenosine; Adult; Anti-Arrhythmia Agents; Atrial Fibrillation; Electric Countershock; Female; Humans; Infusions, Intravenous; Treatment Outcome; Wolff-Parkinson-White Syndrome | 2008 |
Adenosine challenge in the diagnosis of inapparent accessory pathways.
Topics: Adenosine; Adult; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Diagnosis, Differential; Electrocardiography; Heart Conduction System; Humans; Injections, Intravenous; Male | 2007 |
Effect of atrial fibrillation on atrial blood flow in conscious dogs.
Topics: Adenosine; Animals; Atrial Fibrillation; Cardiac Output; Cardiac Pacing, Artificial; Coronary Circulation; Dogs; Heart Atria; Heart Ventricles; Tachycardia | 1983 |
Intravenous adenosine during atrioventricular reentrant tachycardia: induction of atrial fibrillation with rapid conduction over an accessory pathway.
Topics: Adenosine; Atrial Fibrillation; Electrocardiography; Humans; Infusions, Intravenous; Male; Middle Aged; Pre-Excitation Syndromes; Tachycardia, Atrioventricular Nodal Reentry | 1995 |
A technique for measurement of the extent of spatial organization of atrial activation during atrial fibrillation in the intact human heart.
Topics: Adenosine; Atrial Fibrillation; Atrial Flutter; Cardiac Catheterization; Electrocardiography; Electrophysiology; Heart; Heart Atria; Humans; Mathematics; Procainamide; Reproducibility of Results; Signal Processing, Computer-Assisted | 1995 |
Effects of adenosine on atrial refractoriness and arrhythmias.
Topics: Action Potentials; Adenosine; Animals; Atrial Fibrillation; Dipyridamole; Dogs; Dose-Response Relationship, Drug; Electric Stimulation; Heart Atria; Myocardium; Theophylline | 1994 |
Therapeutic and diagnostic utility of adenosine during tachycardia evaluation in children.
Topics: Adenosine; Adolescent; Adult; Apnea; Arrhythmia, Sinus; Atrial Fibrillation; Atrial Function; Atrioventricular Node; Bradycardia; Child; Child, Preschool; Drug Interactions; Electrocardiography; Electrophysiology; Heart Block; Humans; Infant; Infant, Newborn; Injections, Intravenous; Tachycardia; Tachycardia, Atrioventricular Nodal Reentry; Tachycardia, Ventricular; Theophylline | 1994 |
Haemodynamic deterioration after treatment with adenosine.
Topics: Adenosine; Adult; Atrial Fibrillation; Electric Countershock; Electrocardiography; Female; Hemodynamics; Humans; Tachycardia | 1994 |
Effects of intravenous adenosine in patients with preexcited junctional tachycardias: therapeutic efficacy and incidence of proarrhythmic events.
Topics: Adenosine; Adolescent; Adult; Atrial Fibrillation; Cardiac Pacing, Artificial; Electrocardiography; Female; Heart Conduction System; Humans; Male; Middle Aged; Pre-Excitation Syndromes; Reproducibility of Results; Tachycardia | 1994 |
Spatial and temporal inhomogeneity of adenosine's effect on atrial refractoriness in humans: using atrial fibrillation to probe atrial refractoriness.
Topics: Adenosine; Adult; Aged; Atrial Fibrillation; Electrocardiography; Female; Heart Atria; Humans; Male; Middle Aged | 1994 |
Ventricular fibrillation following adenosine administration. A case report.
Topics: Adenosine; Aged; Aged, 80 and over; Atrial Fibrillation; Female; Humans; Ventricular Fibrillation | 1993 |
Acceleration of the ventricular response in paroxysmal lone atrial fibrillation following the injection of adenosine.
Topics: Adenosine; Adult; Atrial Fibrillation; Electrocardiography; Humans; Male; Tachycardia, Supraventricular | 1993 |
Adenosine-induced atrial fibrillation.
Topics: Adenosine; Adult; Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Female; Humans; Male; Middle Aged; Recurrence; Tachycardia, Supraventricular; Time Factors | 1996 |
Carotid sinus pressure: a new application of an old maneuver. A preliminary report.
Topics: Adenosine; Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Blood Pressure; Carotid Sinus; Electrocardiography; Female; Heart Rate; Humans; Infusions, Intravenous; Lidocaine; Male; Middle Aged; Predictive Value of Tests | 1996 |
Myocardial infarction related atrial fibrillation: role of endogenous adenosine.
Topics: Adenosine; Aged; Atrial Fibrillation; Electrocardiography; Humans; Male; Middle Aged; Myocardial Infarction; Myocardium; Purinergic P1 Receptor Antagonists; Theophylline | 1997 |
Adenosine-induced atrial arrhythmia: a prospective analysis.
Topics: Adenosine; Adult; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Electrocardiography; Female; Heart Atria; Humans; Male; Middle Aged; Prospective Studies; Risk Factors; Tachycardia, Paroxysmal; Tachycardia, Supraventricular; Wolff-Parkinson-White Syndrome | 1997 |
Clinical determinants of hemodynamic and symptomatic responses in 2,000 patients during adenosine scintigraphy.
Topics: Adenosine; Age Factors; Aged; Atrial Fibrillation; Cardiovascular Agents; Coronary Angiography; Diabetes Mellitus, Type 1; Female; Hemodynamics; Humans; Linear Models; Logistic Models; Male; Multivariate Analysis; Retrospective Studies; Sex Factors; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 1998 |
Physiology of the escape rhythm after radiofrequency atrioventricular junctional ablation.
Topics: Adenosine; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrioventricular Node; Atropine; Bundle-Branch Block; Cardiac Pacing, Artificial; Cardiotonic Agents; Catheter Ablation; Female; Heart Rate; Humans; Isoproterenol; Lidocaine; Male; Verapamil | 1998 |
[Induction of atrial fibrillation by adenosine in a patient with supraventricular tachycardia].
Topics: Adenosine; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Electrocardiography; Humans; Male; Middle Aged; Pre-Excitation Syndromes; Reproducibility of Results; Tachycardia, Supraventricular | 1998 |
Use of adenosine in patients hospitalized in a university medical center.
Topics: Adenosine; Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Electrocardiography; Female; Heart Conduction System; Hospitalization; Hospitals, University; Humans; Infusions, Intravenous; Male; Middle Aged; Tachycardia | 1998 |
Electrophysiologic effects of adenosine in patients with supraventricular tachycardia.
Topics: Adenosine; Adolescent; Adult; Aged; Aged, 80 and over; Atrial Fibrillation; Child; Child, Preschool; Electrocardiography; Female; Heart; Humans; Infant; Male; Middle Aged; Retrospective Studies; Tachycardia, Atrioventricular Nodal Reentry; Tachycardia, Supraventricular | 1999 |
Plasma adenosine levels and platelet activation in patients with atrial fibrillation.
Topics: Adenosine; Adult; Atrial Fibrillation; Case-Control Studies; Female; Humans; Male; Middle Aged; P-Selectin; Platelet Activation; Receptors, Purinergic P1; Theophylline | 1999 |
Adenosine in the diagnosis of wide complex tachycardias.
Topics: Adenosine; Aged; Atrial Fibrillation; Coronary Disease; Diagnosis, Differential; Digoxin; Electrocardiography; Humans; Male; Postoperative Complications; Tachycardia; Verapamil | 1994 |
Effects of adenosine on local stimulus-response latency and induction of atrial fibrillation by premature stimuli.
Topics: Action Potentials; Adenosine; Adult; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Pacing, Artificial; Electrocardiography; Heart Atria; Humans; Reaction Time; Tachycardia, Supraventricular | 1999 |
Atrial fibrillation in the Mahaim syndrome: atrial pacing and adenosine-induced AV block to unmask a Mahaim physiology.
Topics: Adenosine; Atrial Fibrillation; Bundle-Branch Block; Cardiac Pacing, Artificial; Diagnosis, Differential; Electrocardiography; Female; Heart Block; Humans; Middle Aged; Pre-Excitation, Mahaim-Type | 1999 |
Adenosine induced atrial fibrillation precipitating polymorphic ventricular tachycardia.
Topics: Adenosine; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Female; Heart Rate; Humans; Infusions, Intravenous; Myocardial Infarction; Procainamide; Tachycardia, Supraventricular | 2000 |
Electrophysiological effect of adenosine triphosphate and adenosine on atrial and ventricular action potential duration in humans.
Topics: Action Potentials; Adenosine; Adenosine Triphosphate; Adult; Aged; Atrial Fibrillation; Electrophysiology; Heart Atria; Heart Ventricles; Humans; Male; Middle Aged | 2000 |
Adenosine-induced atrial fibrillation.
Topics: Adenosine; Atrial Fibrillation; Humans; Male; Middle Aged | 2000 |
[Administration of adenosine for termination of atrioventricular nodal reentry tachycardia: induction of atrial fibrillation with rapid conduction over an accessory pathway and unmasking of concomitant Wolff-Parkinson-White syndrome].
Topics: Adenosine; Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Female; Humans; Infusions, Intravenous; Middle Aged; Tachycardia, Atrioventricular Nodal Reentry; Wolff-Parkinson-White Syndrome | 2000 |
Arrhythmogenic activity of cardiac muscle in pulmonary veins of the dog: implication for the genesis of atrial fibrillation.
Topics: Acetylcholine; Action Potentials; Adenosine; Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Atrial Fibrillation; Calcium Channel Blockers; Cardiac Pacing, Artificial; Dogs; Isoproterenol; Muscle, Smooth, Vascular; Myocardium; Potassium Channel Blockers; Propranolol; Pulmonary Veins; Sodium Channels; Sotalol; Tetrodotoxin | 2000 |
Inhibitory effects of JTV-519, a novel cardioprotective drug, on potassium currents and experimental atrial fibrillation in guinea-pig hearts.
Topics: Action Potentials; Adenosine; Animals; Atrial Fibrillation; Atrial Function; Calcium Channel Blockers; Carbachol; Cardiovascular Agents; Dose-Response Relationship, Drug; Guanosine 5'-O-(3-Thiotriphosphate); Guinea Pigs; Heart; Heart Atria; In Vitro Techniques; Membrane Potentials; Potassium Channels; Receptors, Muscarinic; Thiazepines | 2000 |
Specificity of the stress electrocardiogram during adenosine myocardial perfusion imaging in patients taking digoxin.
Topics: Adenosine; Aged; Atrial Fibrillation; Cardiotonic Agents; Coronary Disease; Diagnosis, Differential; Digoxin; Electrocardiography, Ambulatory; Exercise Test; Female; Heart Failure; Humans; Infusions, Intravenous; Male; Radionuclide Ventriculography; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Severity of Illness Index; Vasodilator Agents | 2000 |
Two deaths after prehospital use of adenosine.
Topics: Adenosine; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Diagnostic Errors; Electrocardiography; Emergency Medical Services; Fatal Outcome; Female; Humans; Male; Medication Errors; Middle Aged; Tachycardia, Supraventricular | 2001 |
Dysrhythmia's everest.
Topics: Adenosine; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Diagnostic Errors; Emergency Medical Services; Humans; Tachycardia, Supraventricular | 2001 |
Effect of acute atrial fibrillation on phasic coronary blood flow pattern and flow reserve in humans.
Topics: Acute Disease; Adenosine; Adult; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Function; Blood Flow Velocity; Blood Pressure; Coronary Circulation; Female; Heart Atria; Heart Block; Heart Conduction System; Heart Rate; Humans; Male; Middle Aged; Statistics as Topic; Vascular Resistance | 2002 |
ECG of the month. Hammer and nails. Atrial fibrillation.
Topics: Adenosine; Atrial Fibrillation; Electrocardiography; Female; Humans; Middle Aged | 1992 |
Effect of intravenous adenosine on human atrial and ventricular repolarisation.
Topics: Action Potentials; Adenosine; Atrial Fibrillation; Dose-Response Relationship, Drug; Drug Administration Schedule; Heart; Heart Atria; Heart Ventricles; Humans; Injections, Intravenous; Propranolol | 1992 |
Adenosine-induced atrioventricular block: a rapid and reliable method to assess surgical and radiofrequency catheter ablation of accessory atrioventricular pathways.
Topics: Adenosine; Adolescent; Adult; Aged; Atrial Fibrillation; Atrioventricular Node; Cardiac Pacing, Artificial; Electrocardiography; Electrocoagulation; Female; Follow-Up Studies; Heart Block; Heart Conduction System; Humans; Male; Middle Aged; Monitoring, Intraoperative; Radiofrequency Therapy; Tachycardia, Supraventricular; Treatment Outcome | 1992 |
Utility of adenosine administration during intraoperative mapping in a patient with the Wolff-Parkinson-White syndrome.
Topics: Adenosine; Atrial Fibrillation; Electrocardiography; Heart Conduction System; Humans; Intraoperative Care; Male; Middle Aged; Tachycardia, Supraventricular; Ventricular Function; Wolff-Parkinson-White Syndrome | 1991 |
A 21-year-old woman with rapid atrial fibrillation after adenosine administration.
Topics: Adenosine; Adult; Atrial Fibrillation; Electrocardiography; Emergencies; Humans; Injections, Intravenous; Tachycardia, Paroxysmal; Tachycardia, Supraventricular | 1991 |
Effects of intravenous adenosine on antegrade refractoriness of accessory atrioventricular connections.
Topics: Adenosine; Adult; Atrial Fibrillation; Atrial Flutter; Atrioventricular Node; Cardiac Pacing, Artificial; Electrocardiography; Electrophysiology; Female; Humans; Male; Propranolol; Wolff-Parkinson-White Syndrome | 1991 |
Adenosine in the diagnosis of broad complex tachycardia.
Topics: Adenosine; Adolescent; Adult; Aged; Atrial Fibrillation; Atrioventricular Node; Cardiac Complexes, Premature; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Evaluation; Electrocardiography; Female; Heart Block; Humans; Male; Middle Aged; Tachycardia; Tachycardia, Supraventricular; Time Factors | 1988 |